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ABSTRACT
Nucleic acid X-ray crystallography faces crystallization as well as phasing challenge. The
Phasing problem could be rationally solved by incorporation of selenium into the DNA or RNA
oligonucleotides, while the crystallization of nucleic acid is still challenging. To address these
challenges without structural perturbation, we decided to explore the atom-specific incorporation
and place a selenium atom on the 2’-beta position to control B-form DNA formation during
crystallization process. Herein we report the first synthesis of the β-2’-MeSe-thymidine (2’SeT)
phosphoramidite and Se-DNAs. We found that the Se-DNAs and Se-DNA-protein complexes
formed crystals most of time with higher quality and diffraction resolution than the non-modified
ones. Surprisingly, the Se-DNA can form crystals up to 600 microns in size, which were frequently
hundreds of times larger in volume than the corresponding native. Moreover, we discovered that
the high-quality Se-DNA crystals offered the diffraction resolution up to 1.15 Å and the Se-

derivatized structure was virtually identical to the native one. In the meanwhile, we synthesized
the β-2’-MeSe-cytidine (2’SeC) phosphoramidite and its DNA oligos. To our surprise, the selenium
modification greatly facilitate crystallization when the modified cytidine was placed at the
terminals of the oligo. The crystal of the Se-DNA formed within a few hours, where the
corresponding native crystalized over 1 week.
Furthermore, we describe the first synthesis of 2’-MeSe-arabinouridine (2’SeU)
phosphoramidite and its DNAs to investigate the structure of DNAs containing the uracil. The Sederivatized DNA X-ray crystal structure (1.25 Å) was virtually identical to the native one.
Interestingly, during the Se incorporation step, we also found that the MeSe group attack the C-4
of the uracil generating a oxazolinyl-selenolester when the N-3 was protected with tertbutyloxycarbonyl (Boc) group which may activate the C-4 position through a n-π* interaction.
Besides the structure studies, we also synthesized the 5-phenylselenium and 5phenyltelenium modified deoxyuridine and incorporated them into DNA oligos to investigate their
charge transport properties. The conductance and current-voltage (I-V) characteristics
measurement indicates that the Te modification more effectively manipulate the electronic
structure of the DNA compared to the Se modification and the corresponding native.
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1

GENERAL INTRODUCTION

Nucleic acids (including DNA and RNA) is essential and ubiquitous genetic materials in
living cells. Although targeting proteins has always been the mainstream of therapeutic
development and drug discovery, there is a trend in recent years to choose nucleic acids as the
targets for clinical drugs, such as anticancer drugs. Therefore, more 3D structural information of
nucleic acids is required for designing this kind of novel and effective drug. In the past decade,
our group has been focusing on the selenium atom-specific modification (SAM) on nucleic acids,
which has already been proved to have the potential for crystallization facilitation and structure
determination of nucleic acid and protein-nucleic acid complexes. The brief background and
current progress of SAM for structural and functional studies of nucleic acid as well as drug
discovery are summarized in this chapter.
1.1

Background
DNAs and RNAs are essential biomolecules in cells that is responsible for genetic

information storage, replication and transcription, and also have been considered as potential drug
targets, especially for anticancer drugs.1-8 Moreover, they have also been widely applied to
biotechnology and nanotechnology9-16. DNAs and RNAs can fold into many different shapes and
structures in addition to classical duplexes17-19, such as triplexes20, quadruplexes21, 22, Hollidays
Junctions23 and i-motifs24, let alone the structures formed between nucleic acids and proteins. The
3D-structure determination of nucleic acids and nucleic acid-protein complexes can significantly
enhance nucleic acid-targeted anticancer drug discovery, as well as selective gene silencing
research.
In the past two decades, the development of X-ray crystallographic technologies has largely
facilitated the structure determination of biological macromolecules, of course including nucleic
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acids. More and more novel structure of nucleic acid and nucleic acid-protein complexes have
emerged. At the same time, there are many promising advancements in potential nucleic acidbased therapeutics, including antisense oligonucleotides, siRNAs, microRNAs and aptamers.
These investigations make structural and functional studies of nucleic acid-protein complexes an
increasingly active research field, thereby demanding new methodologies, especially novel
strategies for nucleic acid X-ray crystallography.25
1.2

Challenges in nucleic acid crystallography
1.2.1

Crystallization

However, compared with protein crystallography, there are unique challenges in nucleic
acid X-ray crystallography. One of the long-existing challenge among these is the poor ability of
nucleic acids to form crystals. While a protein molecule has a variety of structural and chemical
groups on its surface to enable crystal contact, the surface of a nucleic acid molecule is full of
negatively charged repetitive phosphate groups, these intrinsic charges as well as its structural
dynamics make the crystal packing of DNA and RNA molecules much more difficult.25 Moreover,
during the crystallization process, the high salt buffer condition would favor A-form DNA duplex
which makes B-DNA crystallization more challenging. The crystallization buffer screening
process is usually labor intensive, and the formation of high-quality crystals is usually rare and
time-consuming. These issues have significantly slowed down the structure determination of
nucleic acids.
Based on previous research, it is possible to tailor the local structure and molecular
dynamics of DNA and accelerate the crystallization process of DNA molecules by the Se atomspecific modification (SAM) strategy26-28. During the past decade, selenium atom in the same
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elemental family of oxygen has been introduced to various locations of nucleotides, especially
nucleobases, to study its unique structural and functional effect on nucleic acids.29-33
1.2.2

Phase problem

As mentioned previously, crystal growth is the first challenge exist in nucleic acid X-ray
crystallography, due to the repulsion of negatively charged backbone and multiple conformations
of oligonucleotides. Besides this, phase problem is another challenge need to be overcome. During
the diffraction data analysis, the application of a Fourier transformation is required to construct the
electron density map of the macromolecule. In the Fourier transformation, both of the structure
factor amplitude F and phase of the reflection α are needed for calculation of the electron density.
The former can be measured during the X-ray diffraction experiment. However, the phase
information is missing which is critical to produce the correct crystal structure.
There are several different strategies were applied to address this issue, such as
isomorphism replacement (SIR; MIR), molecular replacement (MR) and anomalous dispersion
techniques (SAD; MAD). (Table 1.1) With an available similar model, MR should be the most
convenient method which don’t need to obtain a heavy-atom derivative. However, for novel
structures, especially nucleic acid which containing highly repetitive and stacked units34,
molecular replacement will be very difficult to solve the phase problem due to the lack of a
homolog model. Thus heavy-atom method was necessary in order to solve the problem.
Isomorphous replacement was successfully used in protein crystallography by soaking and cocrystallization with heavy-metal cations which often cause randomly hydrolyzation of the
phosphate backbone. Moreover, it also required to prepare many isomorphous native crystals and
heavy-atom derivatives to get the structure determined. Compared with isomorphous replacement,
MAD technique only require one single crystal to obtain all the diffraction needed for the structure
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determination, which provides a good solution to the phase problem of nucleic acid structure
determination.
Table 1.1 Methods to solve the phase problem of nucleic acid crystallography
Methods
Requirement
Techniques
Direct method
Short oligonucleotides and highresolution data
Molecular replacement Good homolog model
Isomorphous
Heavy-atom derivatives
Heavy metal cation soaking or coreplacement
crystallization
MAD/SAD phasing
Heavy-atom derivatization
Bromine derivative
Indirect selenium derivatization
(Se-Met-U1A method)
Direct selenium derivatizations
1.3

Advantages of SAM on NAs
All heavy-atom used in MIR plus many that are too light for MIR can be used as anomalous

scattering center for MAD, such as Se, Br, Hg, Zn, et al.35 Selenium is the most popular anomalous
scattering atom used for proteins because of the ideal K absorption edge (0.9795 Å) for X-ray
diffraction experiment and the minimal structure perturbation. Selenium derivatives of nucleic
acids was also developed and achieved great success in facilitating crystal growth and solving
phase problem which are the two major problems in nucleic acid crystallography. During data
collection, traditional 5-halogen derivatives are significantly affected by radiation damage. In
contrast, radiolysis had little effect on selenium modified nucleic acids.36 Selenium could also
provide similar phasing power as bromine37 and have more modification site to choose than
bromine since it is in the same group as oxygen in the periodic table which can be replaced with
selenium in principle (Figure 1.1). Previous studies on selenium modified nucleic acid X-ray
crystallography show that the selenium modification facilitate the crystal growth generally28, 38-44
and without significant structure perturbations37, 45. It also facilitates the structure determination of
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protein-nucleic acid complex, which helped to study the function and mechanism of enzyme such
as RNase-H46, 47.

Figure 1.1 Se-modifications on nucleosides
A theoretical study48 reveals that the 2’-methylseleno modification facilitate the
crystallization of A-form DNA by destabilize the B-form helix. The large methylseleno-group
cannot tolerate a B-helix geometry due to the steric hindrance with neighboring residues, but it is
fitting well in the minor groove of the A-form helix, which serve as the origin of B- to Aconversion and further facilitate the crystallization. (Figure 1.2)

Figure 1.2 2’-SeCH3 groups implanted in A and B helical structures48
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1.4

Recent advance in Se-derivatized nucleic acids (SeNA)
The study of Se-derivatized nucleic acids (SeNA) was started since 2001 and different kind

of Se-modifications were incorporated into DNA and RNA for structural and functional studies.
Those work has been well reviewed25. Recent years, more novel selenium modified nucleosides
and nucleotides have been synthesized. Herein, we will discuss the synthesis of those novel
modifications and their applications.
1.4.1

New modifications and structures

1.4.1.1 Se-modifications on sugar and phosphate
By using a protection-free one-pot triphosphates synthesis strategy

36

, Lin et al.

successfully synthesized nucleoside 5’-(α-P-seleno)-triphosphates (NTPαSe) and incorporate it
into RNAs by T7 RNA polymerase

49

. During the triphosphates synthesis, the phosphitylating

reagent was generated in situ without any purification and the reaction was highly regioselective
at the 5’-hydroxyl group of nucleosides containing no protecting group on the sugar nor
nucleobases. The selenium was introduced after being treated with the phosphitylating reagent by
adding 3H-1,2-benzothaselenol-3-one (BTSe) at room temperature followed by hydrolysis.
(Scheme 1.1) The NTPαSe analogs were purified by boronate affinity method which using the
strong interaction between the cis-diols at the 2’ and 3’ positions of NTPs and boronate to separate
NTPαSe analogs with other impurities. Compared with conventional HPLC method, the boronate
affinity column give larger capacity for large-scale synthesis with less purification time and steps.
Another new modification containing selenium at the 5’-position of thymidine was summarized in
chapter 2.
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Scheme 1.1 Synthesis of the NTPαSe analogs
1.4.1.2 Se-modifications on nucleobase
2-selenium modified thymidine and uridine synthesis and modified DNA/RNA structure
studies were reported which showing unique ability to enhance the base pairing specificity at the
atomic level. Both studies were reviewed in chapter 2 and chapter 4 respectively. Besides the 2Se-derivatized uridine, the selenium was also incorporated into the 4-positon of uridine to probe
the U/U and U/A base pair which is also summarized in chapter 4.
6-Se-guanosine phosphoramidite, which can also be used as probe to study the RNA
secondary structures, and RNAs was synthesized by Salon et al. in 201346. The

Se

G-RNA also

shows yellow color which is useful for protein-RNA co-crystallization visualization. It was
observed that the Se-modification fit better in the bulge and wobble structure than a duplex
structure. 6-Se-G-modified-RNA/DNA/RNase H complex crystallization was conducted by Salon
et al.46 The study shows that Se-modification was remove by hydrolysis naturally during the
crystallization. However, surprisingly, high quality crystals were generated, and the structure of
RNA/DNA/RNase H complex was determined by the molecular replacement with high resolution
(1.60 Å, PDB: 3ULD) contrasted to the corresponding native RNA complex with DNA and RNase
H (2.70 Å).
1.4.2

Functional study of SAM

Selenium-derivatized nucleic acids were also applied to functional studies such as RNase
cleavage. The duplexes of 6-Se-G-modified-DNA/RNA were complexed with RNase H and the
structure was reported with 1.80 Å resolution (PDB: 3TWH). A mechanism study was conducted
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based on this high-resolution structure and compared with the corresponding native
RNA/DNA/RNase H complex structure (PDB: 2G8U)47. In the native structure, the RNase H binds
to the junction of two RNA/DNA duplexes. However, with modified Se-DNA/RNA duplex, the
RNase H recognizes the internal position, which has the same sequence as in the native complex
structure. The structure also shows that the selenium modification introduces a subtle duplex
unwinding by 0.5-0.7 Å, and the scissile phosphate was shifted closer to the transition state of the
catalytic hydrolysis which significantly accelerating the RNA cleavage by 6.2-fold faster. In the
meanwhile, the scissile phosphate also positions the water nucleophile in the structure by forming
a hydrogen bond (3.10 Å). These studies help us have better understanding of the guide-dependent
RNA cleavage.
1.5

Potential in clinical therapeutic and drug development
Compared to protein, nucleic acid attracted much less attention as drug targets in the

structure-based drug design (SBDD), partially because the lack of structural information of nucleic
acids with drug candidates. By facilitating the crystallization and improving crystal quality (ref),
SAM strategy can greatly promote the SBDD of nucleic acids. Those detailed 3D structure can
help researcher understand the structure of drug target or even the interactions between the targets
and small molecule ligands.
Moreover, oligonucleotides itself has been studied for over 30 years as potential
therapeutics. The major oligonucleotides therapeutics containing antisense oligonucleotides
(ASOs), aptamers, ribozymes and siRNAs, were studied extensively and lots of progress has been
achieved. However, until 2017, there are only six drugs approved by FDA.50 Many obstacles slow
down the development of DNA/RNA-based therapies including the vulnerability to nucleases, offtarget effects, poor delivery and low affinity. Lots of chemical modifications of nucleic acids were
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developed to conquer those challenges such as phosphorothioate (PS), 2’-O-methyl (2’-OMe),
locked nucleic acids (LNAs), phosphorodiamidate morpholino oligomer (PMO) and so on51, which
can increase affinity, nuclease resistant, delivery and reduce off-target effects by altering the
structure and charge of the oligonucleotides.
Previous study on Se-modified nucleic acid shows that replacement of the non-bridging
oxygen of DNA and RNA backbone phosphates protect the oligonucleotide from degradation by
nucleases52, 53. Thus, the Se-modified siRNA may have improved RNase resistance, suggesting a
potential therapeutic application on RNAi. Moreover, certain modifications, such as 2’-MeSe,
reduce multiple conformation of nucleic acid by destabilizing other unfavorable structure48 which
can potentially increase the affinity and specificity of DNA/RNA duplex by reducing entropic
penalty. The consequent longer half-life allowing effect delivery to tissues of interest. Furthermore,
anticancer activity of selenium-modified nucleotides was also reported.54
Overall, Se-derivatized nucleic acids (SeNA) possess many unique properties and show
great potential in clinical therapeutic as well as drug development. However, the studies on SeNA
are still limited and the synthesis is relatively costly, which may prevent broader applications. We
expect that further progress and applications of SeNA will be achieved in future.
1.6

Conclusions and Perspectives
In conclusion, selenium modification has been introduced into nucleosides and nucleotides

at different position. The phasing problem could be solved rationally with the introduced selenium
atom via anomalous diffraction. The modified DNAs/RNAs has been applied to a series of
structure and function studies46, 47, 55-58 and exhibit various functions and applications such as speed
up A-DNA crystallization or enhance base pair specificity.
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Although the B-DNA crystallization still a challenge, it is reasonable and possible to
facilitate crystallization, tailoring dynamics of DNA molecules, especially local dynamics by the
Se-atom-specific modification (SAM) strategy, without causing significant structure and function
perturbations. By replacing oxygen atom with selenium for the phase determination in
crystallography, selenium atom in the same elemental family of oxygen has been introduced to
various locations of nucleic acids, especially nucleobases, without causing significant structure
and function perturbations. In addition, the selenium-atom-specific modification (SAM) provides
the mechanistic insights into the DNA crystallization and inter- and intra-molecular interactions,
thereby facilitating discovery of the small-molecule drugs that target nucleic acids as well as
nucleic acid therapeutics such as siRNA, microRNA, aptamer and antisense oligonucleotides.
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2

2’-MeSe-ARABINOTHYMIDINE MODIFICATION FACILITATES LARGE B-DNA
CRYSTALLIZATION FOR NEUTRON AND X-RAY STRUCTURE STUDY

2.1

Introduction
Structural biology, where X-ray crystallography is one of the most powerful methods, can

greatly promote the biomolecular mechanistic research and drug discovery through examining the
3D structures of macromolecules, particularly proteins and nucleic acids. Currently, more than
140,000 protein structures and more than 3,000 nucleic acid structures have been determined, and
over 85% of them have been solved through X-ray crystallography.59, 60 However, there are two
major challenges in crystallography: crystallization and phase determination (phasing), which
largely slow down structure determination of these bio-macromolecules. Selenium derivatization
strategy for proteins has been developed to rationally solve the phasing problem of protein
crystallography, via multi-wavelength or single-wavelength anomalous diffraction (MAD or
SAD), using Se-modified proteins. So far, over two thirds of novel protein structures are
determined in this fashion.35, 61-63
2.1.1

Neutron diffraction for nucleic acid

Inspired by this protein strategy, the selenium-atom-derivatized nucleic acid (SeNA) for
X-ray crystallography has been pioneered and developed for nucleic acids and their protein
complexes, which solves the phasing problem rationally.25, 64, 65 After addressing this problem in
nucleic acid X-ray crystallography, we are taking on the remaining challenge: crystallization of
nucleic acids. It is notoriously difficult and more challenging than that of proteins, due to nucleic
acid negative charges, multiple structures, and chemical heterogeneity caused by synthesis and
purification.66-69 Moreover, it is much more difficult to grow large crystals (approximately 0.5-0.6
mm in size), required for neutron diffraction crystallography.
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Generally, complete information about the nature of macromolecular H-bonds are lacked
in X-ray crystallography due to the low X-ray scattering power of hydrogen atoms. Neutron
nucleic acid crystallography as a complementary of X-ray can determine the orientation of water
molecule with a relatively low-resolution diffraction data (2.5-2.6 Å) because of the neutrons
scatter off atomic nuclei instead of electron clouds.70, 71 Thus, even the lightest atom, hydrogen,
can be observed directly. In the meanwhile, the neutrons do not cause direct radiation damage
compared to X-ray diffraction, which can produce damage-free biomacromolecular structures and
the data can be collected equally well at room and cryo temperatures. A joint X-ray/neutron
structure of a self-complementary A-DNA oligonucleotide at both room and cyro temperatures
was reported recently which containing 2’-SeMe modification on Cyt5.72 Interestingly, a subtle
difference in the structure between different temperature was observed in which a proton is
replaced with hydrated Mg2+ upon cooling the crystal to 100 K on a backbone phosphate oxygen
indicating a favorable metal binding at low temperature (Figure 2.1). Moreover, because most of
crystal structures were obtained under cyro temperature, the enzyme mechanism or biological
function established base on those structures may leading to significant error. The neutron
crystallography has the advantage over X-rays diffraction in several aspects. However, the
requirement of large crystal volume, generally >0.1 mm3 for nucleic acids and >1 mm3 for protein,
largely restrict the application and development of neutron crystallography.
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Figure 2.1 Joint X-ray/Neutron Structure of the A-DNA
2.1.2

Selenium modifications on thymidine

2.1.2.1 Selenium modified on nucleobase of thymidine
Selenium functionality was incorporated in the nucleobase of thymidine as different
position including replacement of 2-28 and 4-oxygen42,

73

as well as 5-methyl group38. To

synthesize the 4-Se-thymidine (Scheme 2.1), the 4-position needs to be activated via the formation
of triazolide, followed by the Se introduction using di(2-cynoethyl) diselenide reagent74.
Interestingly, When the selenium moiety was introduced to the 2-positon of the nucleobase, the
corresponding nucleoside triphosphate as well as the DNA exhibits yellow color and a significant
red shift was observed in the UV absorption (Figure 2.2).73 Crystal structure study reveals that the
replacement of O with Se on the nucleobase does not cause significant perturbation on the duplex
structure as well as the formation of Se-mediated hydrogen bond with the T:A pair.42
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Figure 2.2 UV spectra of TTP (red) and SeTTP (gray). Inset: left: TPP (colorless); right: SeTPP
(yellow).

Scheme 2.1 Synthesis of 4-Se-T phosphoramidite and Se-DNA. (a) TMS-Im and CH3CN; (b)
triazole-POCl3-Et3N; (c) (NCCH2CH2Se)2/NaBH4, EtOH; (d) 10% Et3N in MeOH; (e) 2cyanoethyl N,N-diisopropylchlorophosphoramidite and N,N-diisopropylethylamine in CH2Cl2;
(f) the solid-phase synthesis.
Selenium has also been successfully incorporated into the 2-position of thymidine started
from 2-thiothymidine derivative (Scheme 2.2). The biophysical and structure studies indicate
that the bulky 2-Se atom discourage the T:G wobble and T:C base pairs due to the steric
hindrance as well as the electronic effect, which enhance base-pairing fidelity without destabilize
the DNA duplex.28 In the 5-Se-thymidine modified DNA structure38, a novel C-H∙∙∙O hydrogen
bond between the MeSe- and the phosphate group was observed which provide new insight into
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atomic mechanisms of phosphorylation and dephosphorylation. Moreover, a 4, 5-diSe-modified
thymidine and its DNA synthesis was also reported75.

Scheme 2.2 Synthesis of 2-Se-T phosphoramidite and Se-DNA. (a) DMTr-Cl, Pyridine, DMAP,
rt; (b) DBU, DMF, CH3I; (c) Se, NaBH4, EtOH; (d) I-CH2CH2CN, i-Pr2NEt, CH2Cl2; (e) (iPr2N)2P(Cl)OCH2CH2CN, (i-Pr)2NEt, CH2Cl2; (f) Solid-phase synthesis.
2.1.2.2 Selenium modified on sugar of thymidine
The synthesis of 5’-Se-derivatized thymidine and its phosphoramidite was reported by
Zhang et al., which was then successfully incorporated into DNA oligo through solid-phase
synthesis76. The protected Se-functionality was introduced within two steps with 71% yield in
total. With the 5’-Se-moiety, the fluorescent group can be easily incorporated into DNA during
the deprotection step under a mild condition. It was also observed that the labeled DNA is well
recognized by DNA polymerase which could be used in bioreaction monitoring or disease
diagnosis.
Another selenium modification which contains a methylseleno group on the 2’-position of
thymidine was synthesized (Scheme 2.3) and found largely facilitated the crystallization of
modified A-DNA compared to the native DNA. The thermal denaturing study reveals that the Se
derivatization did not cause significant perturbation of the duplexes structure, which is consistent
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with the crystal structure results43. Base on the structure, the 2’-Se-furanose displays the 3’-endo
sugar pucker and the 2’-methylseleno group is placed in the minor groove of the duplex.

Scheme 2.3 Synthesis of 5’-DMTr-2’-MeSe-thymidine phosphoramidite
As mentioned above, crystallization is a bottle-neck step in crystallography. While, the
crystallization of B-form DNA is even more challenging because of the high salt conditions during
the crystallization process disfavoring the B-form duplex formation. Base on the previous study
that the 2’-MeSe-thymidine modified oligonucleotides was found to largely facilitate the
crystallization of A-form DNA while retaining high diffraction quality and did not cause
significant structure perturbation.77 We hypothesize that 2’-MeSe-arabinothymidine may
facilitates the B-DNA crystal packing which helps the formation of large crystals.
We reported here the first synthesis of 2’-MeSe-arabinothymidine phosphoramidite and its
incorporation into oligonucleotides. The Se-DNA give high quality crystal comparing to the
corresponding native DNA and facilitates large crystal growth up to 0.6 mm in size. Moreover,
our biophysical and structural studies reveal that the Se-DNAs retain a similar structure compared
to the native DNAs without significant perturbation. The B-factor comparison between the SeDNA and the native reflects the impact of the selenium derivation on the local structure flexibility
without affects the global molecular dynamics.
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2.2

Results and discussion
2.2.1

The synthesis of 2’MeSe-arabinothymidine and its DNA oligonucleotide

The synthesis of 2’-MeSe-arabinothymidine derivative (8) started from the protection of
the 5’-, 3’-hydroxyl groups of thymidine (1) with tetraisopropyldisilylene (TIPDS). To avoid the
generation of 2’-MeSe-ribothymidine,43 protection of the 3-N is required before the MeSe
functionality incorporation. The protective group needs to be stable enough to tolerate the Se
introduction condition, and, in the meanwhile, deprotected easily afterwards without affect the
incorporated MeSe group. Initially, we attempted different protective groups including benzyl,
benzoyl and tert-butyloxycarbonyl (BOC). The benzyl group is stable enough for the Se
incorporation, however, difficult to remove possibly due to the selenium functionally “poisoned”
the catalyst during the hydrogenation deprotection. The problem was later overcome by using
Benzyloxymethyl acetal (BOM) as protecting group, which can be later cleaved with strong acid.
After the BOM protection, the 2’-OH was activated by mesylate. Then the MeSe incorporation
was conducted at a high temperature (90 oC) in THF in a pressure vessel, which give 80% yield in
6 h. After the deprotection of BOM, 6 was treated with HF to remove the TIPDS group and the 5’OH was selectively protected with the DMTr group. Finally, the 2’-Se-arabinothymidine (8) was
converted to corresponding phosphoramidite (9) in 90% yield. (Scheme 2.4)
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Scheme 2.4 Synthesis of 5’-DMTr-2’-MeSe-arabinothymidine phosphoramidite and Se-modified
Oligonucleotides
The phosphoramidite 9 was incorporated into DNA oligos via standard solid-phase
synthesis. The Se functionality was found stable with the treatment of I2 (20 mM, 20 s) and
trichloroacetic acid (TCA) during the oligo synthesis. The synthesized DNA oligo was cleaved off
the solid support and fully deprotected by treating with concentrated ammonia at 55 oC for 5 h,
followed by the reverse-phase HPLC purification. All the purified DNA oligo was further
confirmed by MALDI-TOF MS analysis (Table 2.1). Figure 2.3 shows the typical selenium
isotopic distribution of the Se-DNA.
Table 2.1 MALDI-TOF MS Data of Se-DNAs
Entry
Se-oligonucleotides
a
B-Ts1
5’-CGCGAA2’SeTTCGCG-3’
C117H149N46O70P11Se FW 3739.4
b
B-Ts2
5’-CGCGAAT2’SeTCGCG-3’
C117H149N46O70P11Se FW 3739.4
c
B-Td3
5’-CGCGAA2’SeT2’SeTCGCG-3’
C118H151N46O70P11Se2 FW 3833.5
d
Rnase-s1

Measured (calcd) m/z
[M+H]+: 3740.1 (3740.4)
[M+H]+: 3740.1 (3740.4)
[M+H]+: 3834.8 (3834.5)
[M+H]+: 1901.5 (1901.3)
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5’-A2’SeTGTCG-3’
C60H77N22O35P5Se FW 1900.3
Rnase-s2
5’-ATG2’SeTCG-3’
C60H77N22O35P5Se FW 1900.3
Rnase-d3
5’-A2’SeTG2’SeTCG-3’
C61H79N22O35P5Se2 FW 1994.2

e

Intens. [a.u.]

f

[M+H]+: 1901.4 (1901.3)
[M+H]+: 1995.4 (1995.2)

x10 4
3740.123

1.2

3739.045

1.0

3741.092
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Figure 2.3 Typical selenium isotopic distribution of Se-DNA
2.2.2

Thermostability and Circular dichroism studies

To compare the thermostability of the Se-modified oligonucleotides with the
corresponding native DNA, the UV denaturation experiment was conducted. The results, presented
in Table 2.2, show that the melting temperatures are similar between the Se-modified DNA and
the native ones, indicating that the Se functionality does not cause significant perturbation. Circular
dichroism (CD) was also carried out to study their structure change in the solution. Positive peaks
at 280 nm, 220 nm and negative peak at 245 nm were observed in all oligos, and no shift was
founded comparing to the native DNA, which suggested that the native and Se-DNAs has similar
helixes in solution. (Figure 2.5)
Table 2.2 Melting temperature of Native and Se-DNA duplexes
Entry

Sequence

Melting
temperature (℃)

ΔTm(℃)
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a

5’-CGCGAATTCGCG-3’

64.0

-

b

5’-CGCGAASeTTCGCG-3’

61.5

2.5

c

5’-CGCGAATSeTCGCG-3’

61.1

2.9

d

5’-CGCGAASeTSeTCGCG-3’

55.8

8.2

Native
T-DNA1
Se
T-DNA2
Se
T-DNA3

1.0

Se

Normalized Abs

0.8

0.6

0.4

0.2

0.0
0

20

40

60

80

100

Temperature oC

Figure 2.4 Normalized UV melting curves of DNAs.
The native DNA duplex: (5’-CGCGAATTCGCG-3’)2. The SeT-DNA1 duplex: (5’CGCGAASeTTCGCG-3’)2. The SeT-DNA2 duplex: (5’-CGCGAATSeTCGCG-3’)2. The SeT-DNA3
duplex: (5’-CGCGAASeTSeTCGCG-3’)2.

Figure 2.5 circular dichroism spectroscopy of native and SeT-DNAs.
The native DNA duplex: (5’-CGCGAATTCGCG-3’)2. The SeT-DNA1 duplex: (5’CGCGAASeTTCGCG-3’)2. The SeT-DNA2 duplex: (5’-CGCGAATSeTCGCG-3’)2. The SeT-DNA3
duplex: (5’-CGCGAASeTSeTCGCG-3’)2.
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2.2.3

Large crystal growth facilitated by the modification

In the meanwhile, we also monitored the crystal growth of the native and modified DNA
oligos under different buffer conditions (Appendix B). Interestingly, the SeT-modification slow
down the crystal growth dramatically (Figure 2.6, left). And, in each droplet, there is one crystal
formed compare to the native which generally form 2-10 small crystals. Attributing to the slow
growth, the SeT-DNA form crystals that generally 40 – 60 times larger in volume than the native
under same buffer condition, and the largest crystal is up to 600 microns (Table 2.3). 1 mM single
strand concentration is required for the crystal growth. The improved crystal volume with Semodified DNA may help break the bottleneck of crystal volume for neutron crystallography. We
are currently in the process of neutron diffraction experiment.
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Figure 2.6 Comparison of crystal growth between native and SeT-DNA2.
Left: the comparison of the rate of crystal growth between SeT-DNA2 and the corresponding
native; Right: the comparison of the size of crystals between SeT-DNA2 and the corresponding
native.
Table 2.3 crystal comparison of SeT-DNA2 and the native
Se-DNA2
Se-DNA2
Native-DNA
buffer #9
buffer #10
buffer #9

Native-DNA
buffer #10
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2.2.4

Structure determination of modified DNA and protein-DNA complex

The determined crystal structure (1.15 Å resolution) of Se-DNA (Figure 2.7) is
superimposable to the corresponding native structure (1.26 Å resolution) with same space group,
and the structures were virtually identical indicating that the selenium modification at 2’-position
does not cause significant structure perturbation. The structure reveals that the 2’-Se-arabinofuranose displays the 2’-endo sugar pucker and the 2’-methylseleno group is in the major groove
of the B-DNA duplex. The Se-modified and the native structures are also virtually identical with
a RMSD of 0.176Å for all 454 atoms which support that the incorporation of 2’-MeSearabinothymidine does not alter the global structure of the complex (Figure 2.7). The data
collection and structure refinement statistics are summarized in Table 2.4.
Table 2.4 Data collection and refinement statistics of SeT-DNA and the corresponding native
Data Collection
SeT-DNA2
Native
Wavelength (Å)
1
1
Resolution range (Å)
50 - 1.15
50 - 1.26
(1.17 – 1.15)
(1.28 - 1.26)
Space group
P 21 21 21
P 21 21 21
Unit-cell a, b, c (Å)
25.4, 40.0, 65.7
25.5, 40.2, 65.7
90, 90, 90
90, 90, 90
𝛂, 𝛃, 𝛄 (º)
Number of reflections
24146 (1078)
18494 (904)
Completeness (%)
98.6 (93.5)
98.0 (97.0)
I/σ
45 (10)
26 (4.8)
R merge (%)
3.8 (24.9)
5.7 (50.3)
Refinement
Resolution range (Å)
34.18 - 1.15
34.31 - 1.26
Number of reflections
22851
17319
Completeness (%)
98.4
96.5
R value (%)
20.7
20.6
R free (%)
22.5
23.2
Average B value (Å2)
17.9
16.4
Rms Bond Length (Å)
0.019
0.014
Rms Bond Angle (º)
2.08
1.91
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Figure 2.7 A. Global and B. local structure of the SeT-DNA2 [5’-CGCGAAT-SeT-CGCG-3’] with
a resolution of 1.15 Å. (Se-DNA, red; Native DNA, cyan); C. Hydration pattern comparison.
The impact of 2’-arabino-SeMe-dT modification on duplex hydration was also studied.
The comparison between the modified DNA and the corresponding native show similar hydration
pattern in both minor groove as well as major groove (Figure 2.7, C). The introduction of MeSe
group repulses one of the water molecule away which may cause minor hydration alteration in the
major groove of duplex.
When examine the crystal contact between DNA molecules, we found that the selenium
functionality at the second thymidine (5’-CGCGAATTCGCG-3’) would not affect their
interaction (Figure 2.8). However, the methylseleno-group located on the first thymidine (5’-
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CGCGAATTCGCG-3’) may have direct interaction with the nearby DNA molecule which could
further influence the crystal packing and growth.

Figure 2.8 Packing of 2’SeT-modified DNA (5’-CGCGAATTCGCG-3’)
Bst DNA polymerase is a member of the DNA polymerase I family responsible for
maintaining the genomic integrity which has been extensively studied as a model system for DNA
synthesis. Here, the crystal of the fragment DNA polymerase with DNA oligo containing 2’-βMeSe located on two different thymidine (5’-CGCGAA-SeT-TCGCG-3’ and 5’-CGCGAAT-SeTCGCG-3’) were grown (Figure 2.9) and the structures were determined at 2.64 Å and 2.90 Å
respectively. The data collection and structure refinement statistics are summarized in Table 2.5.
The modified BST-DNA structures were superimposed with the corresponding native structure
and show no significant perturbation in its global geometry (Figure 2.10, left). However, by
comparing the sugar conformation in the duplex, we found that the location of the modification
will directly change the sugar puckering. When the 2’-MeSe group was located at the first T of the
sequence from the 5’-end, the sugar conformation of the modified thymidine was changed to 3’endo, which normally exist in the A-form DNA, on only one of the chain in the duplex with
another chain retain the same sugar puckering. Moreover, the MeSe group was pointed into the
minor groove of the DNA duplex (Figure 2.10, right). While, when the selenium moiety was
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located on the second T, the sugar pucker of the thymidine exhibits same conformation as the
native oligonucleotides with the MeSe group pointed to the major groove (Table 2.6).

Figure 2.9 BST-DNA complex crystal
Table 2.5 Crystallographic data collection and refinement statistics of SeT-DNA/Bst complex
DNA #
1
2
3
Wavelength (Å)
1
1
1
50.0-1.85
50.0-2.90
50.0-2.64
Resolution range (Å)
(1.92-1.85)
(2.95-2.90)
(2.69-2.64)
Space group
P212121
P212121
P212121
Unit-cell a, b, c (Å)
86.7, 94.1, 105.0
86.9, 94.5, 105.8 89.4, 93.7, 105.3
α, β, γ (°)
90, 90, 90
90, 90, 90
90, 90, 90
Unique reflections
73185(6683)
20086 (980)
26773 (1297)
Completeness (%)
99.1(91.5)
100.0 (100.0)
99.9 (98.8)
Rmerge (%)
7.4 (43.1)
17.4 (55.9)
10.9 (45.9)
I/σ(I)
32.7 (3.6)
17.3 (5.2)
16.5 (3.2)
R value (%)
18.7
16.8
19.0
Rfree (%)
22. 4
23.4
25.2
2
Average B value (Å )
22.6
44.6
39.6
R.m.s.d. bond length (Å) 0.019
0.009
0.009
R.m.s.d. bond angle (°)
1.94
1.64
1.59
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Figure 2.10 The superimposed structure of the fragment of Bst polymerase with DNAs.
(Green, native; cyan, Se-DNA, 5’-CGCGAATTCGCG-3’; Red, Se-DNA, 5’-CGCGAATTCGCG3’)
Table 2.6 Sugar Pucker Confirmation of Bst-DNA complexes
Native
Ts1
#
Base
Chain C
Chain B
Chain C
Chain B
1
C
C3’-endo O4’-exo
C3’-endo O4’-exo
2
G
C3’-endo C3’-exo
C3’-endo C3’-exo
3
C
C3’-endo C1’-exo
C3’-endo C2’-endo
4
G
C2’-endo C2’-endo C3’-exo
C2’-endo
5
A
C2’-endo C2’-endo C3’-exo
C3’-exo
6
A
C1’-exo
C1’-exo
C4’-exo
C2’-endo
7
T
O4’-endo C1’-exo
C3’-endo O4’-endo
8
T
C1’-exo
C1’-exo
C2’-endo C1’-exo
9
C
C2’-endo C2’-endo C2’-endo C2’-endo
10
G
C2’-endo C3’-endo C2’-endo C3’-endo
11
C
C2’-endo C3’-endo C2’-endo C3’-endo
12
G
C1’-exo
O4’-endo C2’-endo C3’-endo

Ts2
Chain C
Chain B
O4’-exo
O4’-exo
C3’-endo C3’-exo
C3’-endo C2’-endo
C2’-endo C2’-endo
C2’-endo C2’-endo
C1’-exo
C2’-endo
O4’-endo C2’-endo
C1’-exo
C1’-exo
C2’-endo C1’-exo
C2’-endo C3’-endo
C2’-endo C3’-endo
C1’-exo
C3’-endo

Rnase H is a sequence-nonspecific endonuclease that digest the RNA of a DNA/RNA
duplex which is involved in many important biological processes as well as silencing gene
expression through antisense mechanism. Here, we also grown the Rnase H-DNA/RNA complex
crystals (Figure 2.11) with a selenium modified thymidine at two different location (5’-A-SeTGTCG-3’ and 5-ATG-SeT-CG-3’). The X-ray crystal structure of RNase H/RNA/Se-DNA
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complex was determined at a resolution of 1.47 Å. Interestingly, when the 2’-β-MeSe group is
located on the first thymidine (5’-A-SeT-GTCG-3’), the complex structure is virtually identical to
the corresponding native (Figure 2.12). However, when the 2’-β-MeSe group is located on the
second thymidine (ATG-SeT-CG-3’), a disordered structure was obtained based on the electron
density map that the DNA/RNA duplex exhibits two possible binding positions with the RNase H
protein (Figure 2.13), which indicates that the selenium moiety may influence the binding site.

Figure 2.11 RNaseH-(SeT)DNA/RNA complex crystals
Table 2.7 Crystallographic data collection and refinement statistics of RNaseH-(SeT)DNA/RNA
complex
DNA #
1
2
3*
Wavelength (Å)
1
1
1
50.0-1.70
50.0-1.48
50.0-1.45
Resolution range (Å)
(1.76-1.70)
(1.51-1.48)
(1.48-1.45)
Space group
C2
C2
C2
Unit-cell a, b, c (Å)
80.2, 37.6, 62.1
81.2, 37.7, 62.1
80.9, 37.7, 62.1
α, β, γ (°)
90, 96.0, 90
90, 96.3, 90
90, 96.8, 90
Unique reflections
18866 (1081)
30461 (1283)
33258 (1608)
Completeness (%)
92.1 (53.7)
97.4 (83.7)
100.0 (100.0)
Rmerge (%)
7.7 (23.5)
6.8 (34.2)
3.3 (46.2)
I/σ(I)
21 (3.5)
26 (4.0)
54 (6.7)
R value (%)
18.9
19.8
Rfree (%)
23.4
22.3
Average B value (Å2) 15.6
15.3
R.m.s.d. bond length
(Å)
0.019
0.014
R.m.s.d. bond angle (°) 1.85
1.91
-
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Figure 2.12 Superimposed structure of RNaseH-SeT-DNA complex (5’-A-SeT-GTCG-3’) with the
native

Figure 2.13 Electron density map of RNaseH-SeT-DNA complex (ATG-SeT-CG-3’)
2.2.5

B-factor comparison

Besides providing the average static picture, X-ray diffraction can further explore the
molecular dynamics through a well-defined parameter so-called B-factor. Crystallographic Bfactor describes the attenuation of X-ray diffraction result from the thermal motion, which reflects
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the rigidity, flexibility and internal motion of the structure.78 However, their interpretation should
be treated cautiously due to the B-factor also correlates with the resolution of the structure. The Bfactor can be up to 100-200 with a resolution as low as 3-5 Å which is ineligible to draw specific
conclusions. Thus, high resolution data is required when interpret the B-factor regarding the
molecular dynamics. The high-resolution data we obtained allows the comparison of the B-factors
between the Se-DNA and the native one, which give insight into the impact of the Se functionality
to the local molecular dynamics. B factors were extracted from the analyzed structures and
normalized using unity-based scaling for comparison.79 The scaled B-factor Bscaled(x) for atom x
was calculated according to the formula
𝐵𝑠𝑐𝑎𝑙𝑒𝑑(𝑥) = 99[𝐵𝑥 − 𝐵𝑚𝑖𝑛 ]/[𝐵𝑚𝑎𝑥 − 𝐵𝑚𝑖𝑛 ] + 1

(1)

Interestingly, large fluctuations of phosphates were observed for both Se-modified and
native DNAs, while the nucleobases are much less flexible (Figure X.). Surprisingly, significant
decrease of the B-factor was observed on one of the DNA strands at the phosphate group of the
Se-T as well as the adjacent cytidine residue compared to the native one which suggesting that the
selenium derivation restricts its movement and enhances rigidity. However, the similar average Bvalue of the Se-DNA (17.9 Å2) and the corresponding native one (16.4 Å2) indicating that the Se
functionality does not change the global molecular dynamics of the DNA duplex significantly.
Consistently, the B-factor comparison between the RNase H-RNA/Se-DNA complex and the
corresponding native shows no significant changes (Figure X).
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Figure 2.14 Comparison of normalized B-factor profiles from Se-DNA (red line) with the
corresponding native (black line)
(The MeSe-group was not included in the profile. Every nucleoside and phosphate group in the
DNA sequence has been labelled and the Se-modified thymidine are highlighted with red font.)
2.3

Conclusion
In conclusion, we developed a route to synthesize the 2’-MeSe-arabinothymide analogues

and oligonucleotides containing selenium modification. High resolution structures were obtained
through X-ray crystallography for both DNA duplex and RNase H/RNA/DNA complex (1.15 Å
and 1.47 Å respectively). The structure shows that the 2’-β-position selenium derivatization retains
the native 2’-endo conformation in the B-form DNA duplex and the modification does not cause
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any significant structure perturbation which is consistent with the UV melting and CD studies
results. The structures of Bst-DNA complex show that the location of the modified nucleoside will
affect the sugar pucker conformation. B-factor comparison shows that the Se-modification restrict
the local molecular flexibility instead of the global molecular dynamics. Furthermore, we observed
that the 2’-Se-araT modified oligo formed larger crystal than the native oligo, which it has potential
to aid the structure study for neutron crystallography.
2.4

Experimental section
2.4.1

General

Most solvents and reagents were purchased from Sigma, Fluka, or Aldrich (p.a.) and used
without purification unless mentioned otherwise. Triethylamine (TEA) was dried over KOH (s)
and distilled under argon. When necessary, solid reagents were dried under high vacuum.
Reactions with compounds sensitive to air or moisture were performed under argon. Solvent
mixtures are indicated as volume/volume ratios. Thin layer chromatography (TLC) was run on
Merck 60 F254 plates (0.25 mm thick; Rf values in the text are for the title products), and
visualized under UV-light or by a Ce-Mo staining solution (phosphomolybdate, 25 g;
Ce(SO4)2·4H2O, 10 g; H2SO4, 60 mL, conc.; H2O, 940 mL) with heating. Flash chromatography
was performed using Fluka silica gel 60 (mesh size 0.040-0.063 mm) using a silica gel:crude
compound weight ratio of ca. 30:1. 1H, 13C and 31P-NMR spectra were recorded using Bruker-300
or 400 (300 or 400 MHz). All chemical shifts (δ) are in ppm relative to tetramethylsilane and all
coupling constants (J) are in Hz. High resolution (HR) MS were either obtained with electrospray
ionization (ESI) on a Q-TOFTM Waters Micromass at Georgia State University.
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2.4.2

Synthesis of phosphoramidite and characterization

3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐ 5-methyl-uridine (2.1) 5-methyluridine (10 g, 38.7 mmol) was suspended in 200 mL dry pyridine with argon and the mixture was
placed in an ice-bath. To the suspension, 1,3-dichloro-1,1,3,3-tetraisopropyl-disiloxane (13.4g,
42.6 mmol) was added dropwise. Then the ice-bath was removed, and the reaction was stirred at
room temperature for 5 h. After the reaction completed, 5 mL of Methanol was added. The solvent
was evaporated under reduced pressure and dissolved in methylene chloride (300 mL). The organic
solution was washed with HCl (3 M, 75 mL), saturated sodium bicarbonate (75 mL), water (100
mL), brine (100 mL), dried over anhydrous MgSO4, and concentrated in vacuum to given 2.1 as
white solid. The product was used in the next step without further purification. 1H-NMR (400
MHz, CDCl3) δ (ppm): 1.03-1.09 (m, 28H, 4×iPrSi ), 1.91 (s, 3H, CH3), 3.31 (br, 1H, OH), 4.01
(dd, J1=2.2 Hz, J2=13.1 Hz, 1H, H-5’), 4.09 (d, J=8.4 Hz, 1H, H-4’), 4.19 (m, 2H, H-2’, H-5’),
4.40 (dd, J1=5.1 Hz, J2=8.4 Hz, 1H, H-3’), 5.71 (s, 1H, H-1’), 7.41 (s, 1H, H-6), 8.91 (br, 1H, NH).
1

H-NMR spectrum is identical to the literature80.

3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐N3-(benzyloxymethylacetal)-5methyl-uridine (2.2) Compound 2.1 (5 g, 10 mmol) was dissolved in 50 mL THF followed by the
addition of 1,8-Diazabicyclo(5.4.0)undec-7-ene (DBU, 4.5 mL, 30 mmol). The mixture was
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treated with benzyl chloromethyl ether (2.7 mL, 20 mmol) and stirred at room temperature for 2
h. The solvent was evaporated under reduced pressure and washed with water (30 mL), brine (50
mL), dried over MgSO4 and concentrated. The residue was purified by silica gel chromatography
(25 % ethyl acetate in hexane) to give desired product 2.2 (5.6 g, 90 %). 1H-NMR (400 MHz,
CDCl3) δ (ppm): 1.03-1.10 (m, 28H, 4×iPrSi), 1.91 (s, 3H, CH3), 2.89 (d, 1H, OH), 4.01 (dd,
J1=2.9 Hz, J2=13.1 Hz, 1H, H-5’), 4.06 (td, J1=3.7 Hz, J2=8.5 Hz, 1H, H-4’), 4.14 (d, J=5.1 Hz,
1H, H-2’), 4.19 (dd, J1=2.0 Hz, J2=13.1 Hz, 1H, H-5’), 4.39 (dd, J1=5.2 Hz, J2=8.5 Hz, 1H, H-3’),
4.72 (s, 2H, CH2OCH2Ph), 5.49 (d, J=3.1 Hz, 2H, CH2OCH2Ph), 5.72 (s, 1H, H-1’), 7.38-7.23 (m,
6H, aromatic, H-6).

13

C-NMR (100 MHz, CDCl3) δ (ppm): 12.7, 12.6 (i-Pr), 13.0 (CH3), 13.5,

13.3, 17.4, 17.4, 17.3, 17.2, 17.08, 17.0, 17.0, 16.9 (i-Pr), 60.4 (C-5’), 69.2 (C-3’), 70.5 (CH2),
72.3 (CH2), 75.1 (C-2’), 81.9 (C-4’), 91.4 (C-1’), 109.9 (C-5), 127.6, 127.7, 128.3 (Ar-C), 134.3
(C-6), 138.0 (Ar-C), 150.7 (C-2), 163.4 (C-4). HRMS (ESI): C30H48N2O8Si2; [M+H]+: 621.1884
(calc. 621.3027). 1H-13C HSQC, 1H-13C HMBC and 1H-1H COSY (Appendix D.1).

2’-O-mesyl-3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐N3-(benzyloxymethyl
acetal)-5-methyl-uridine (2.3) Compound 2.2 (3.5 g, 5.6 mmol) was dissolved in 35 mL THF
followed by the addition of triethylamine (3.1 mL, 22.4 mmol). To the solution, methanesulfonyl
chloride (0.88 mL, 11.2 mmol) was added dropwise and the reaction was stirred at room
temperature for 1 h. The solvent was evaporated under reduced pressure and dissolved in
methylene chloride (100 mL). The organic solution was washed with water (30 mL) and brine (40
mL), dried over MgSO4 and concentrated. The residue was purified by silica gel chromatography
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(15 % ethyl acetate in hexane) to give desired product 2.3 (3.5 g, 90 %). 1H-NMR (400 MHz,
CDCl3) δ (ppm): 1.04-1.10 (m, 28H, 4×iPrSi), 1.93 (s, 3H, CH3), 3.19 (s, 3H, O3SCH3), 4.07-4.16
(m, 2H, H-5’), 4.43-4.44 (m, 1H, H-4’), 4.68 (s, 2H, CH2OCH2Ph), 5.23 (t, J=5.3 Hz, 1H, H-2’),
5.41 (t, J=4.7 Hz, 1H, H-3’), 5.50 (s, 2H, CH2OCH2Ph), 6.14 (d, J=5.2 Hz, 1H, H-1’), 7.25-7.37
(m, 5H, aromatic), 7.40 (s, 1H, H-6).

13

C-NMR (100 MHz, CDCl3) δ (ppm): 12.6 (i-Pr), 12.9

(CH3), 13.2, 13.2, 13.4, 17.2, 17.2, 17.3, 17.3, 17.3 (i-Pr), 38.7 (O3SCH3), 60.9 (C-5’), 70.6 (CH2),
72.2 (CH2), 74.7 (C-3’), 77.2 (C-2’), 83.0 (C-4’), 87.2 (C-1’), 111.2 (C-5), 127.7, 127.8, 128.3
(Ar-C), 133.3 (C-6), 137.8 (Ar-C), 151.1 (C-2), 163.1 (C-4). HRMS (ESI): C31H50N2O10SSi2;
[M+Na]+: 721.2646 (calc. 721.2622). 1H-13C HSQC, 1H-13C HMBC and 1H-1H COSY (Appendix
D.1).

3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐N3-(benzyloxymethylacetal)-5methyl-2’-methylseleno-arabinouridine (2.4) NaBH4 (106 mg, 2.8 mmol) was placed in a
pressure vessel and suspended in 5 mL anhydrous THF under argon. To the solution, Me2Se2 (0.26
mL, 2.8 mmol) was injected, followed by the drop wise addition of 1 mL anhydrous ethanol. The
yellowish color suspension was stirred at room temperature for 30 min. Then, the starting material
2.3 (1 g, 1.4 mmol) was dissolved in 5 mL anhydrous THF and added into the solution. The
reaction mixture was heated up to 95 oC and stirred for 16 h. The solution was concentrated under
reduced pressure and re-dissolved in ethyl acetate (60 mL). The organic solution was washed with
water (30 mL), brine (40 mL), dried over MgSO4, and evaporated to dryness to afford crude
product. The residue was then purified by silica gel chromatography (10 % ethyl acetate in hexane)
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to give desired product 2.4 (0.8 g, 80 %) as white solid. 1H-NMR (400 MHz, CDCl3) δ (ppm):
1.04-1.13 (m, 28H, 4×iPrSi), 1.95 (d, J=1.0 Hz, 3H, CH3), 2.06 (s, 3H, SeCH3), 3.63 (dd, J1=7.4
Hz, J2=9.8 Hz, 1H, H-2’), 3.73 (td, J1=2.4 Hz, J2=8.1 Hz, 1H, H-4’), 4.05 (dd, J1=2.9 Hz, J2=13.2
Hz, 1H, H-5’), 4.12 (dd, J1=2.0 Hz, J2=13.2 Hz, 1H, H-5’), 4.23 (dd, J1=8.5 Hz, J2=9.5 Hz, 1H,
H-3’), 4.68 (d, J=1.7 Hz, 2H, CH2OCH2Ph), 5.53 (s, 2H, CH2OCH2Ph), 6.41 (d, J=7.3 Hz, 1H, H1’), 7.38-7.26 (m, 6H, aromatic, H-6). 13C-NMR (100 MHz, CDCl3) δ (ppm): 6.6 (SeCH3), 12.5,
12.7, 13.0 (i-Pr), 13.3 (CH3), 13.9, 17.0, 17.1, 17.3, 17.4 (i-Pr), 50.2 (C-2’), 60.0 (C-5’), 70.4
(CH2), 71.9 (CH2), 73.6 (C-3’), 83.5 (C-4’), 85.1 (C-1’), 109.9 (C-5), 127.6, 127.7, 128.3 (Ar-C),
134.3 (C-6), 138.0 (Ar-C), 151.3 (C-2), 163.4 (C-4). HRMS (ESI): C31H50N2O7SeSi2; [M+Na]+:
721.2209 (calc. 721.2219). 1H-13C HSQC, 1H-13C HMBC and 1H-1H COSY (Appendix D.1).

3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐5-methyl-2’-methylselenoarabinouridine (2.5) Compound 2.4 (1.8 g, 2.6 mmol) was placed in a round bottom flask, purge
with argon and dissolved in 15 mL anhydrous toluene. The solution was cooled down to -78 oC by
placing in a dry ice-acetone bath. To the solution, BBr3 solution (0.31 mL, 3.1 mmol, 1 M in
hexane) was injected and the reaction was stirring at -78 oC for 1 h. Then, the reaction was
quenched by adding a mixture of triethylamine and anhydrous isopropanol (2 mL, 1:1, v/v),
followed by the remove of the dry ice-acetone bath. The solution was stirred at room temperature
for another 1 h. The reaction was concentrated to around 2 mL and diluted with 50 mL of ethyl
acetate. The organic solution was washed with water (15 mL). The water layer was then extracted
with ethyl acetate (3 x 10 mL), and the combined organic layer was washed with brine (40 mL),
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dried over MgSO4 (s), followed by filtration. The solvent was evaporated under reduced pressure
to afford the crude product. The residue was then purified by silica gel chromatography (15 %
ethyl acetate in hexane) to give desired product 2.5 (1.1 g, 71 %). 1H-NMR (400 MHz, CDCl3) δ
(ppm): 1.04-1.12 (m, 28H, 4×iPrSi), 1.93 (d, 3H, CH3), 2.09 (s, 3H, SeCH3), 3.62 (m, 1H, H-2’),
3.72 (d, J=7.4 Hz, 1H, H-4’), 4.05 (d, J=13.2 Hz, 1H, H-5’), 4.13 (d, J=14.2 Hz, 1H, H-5’), 4.24
(t, J=8.9 Hz, 1H, H-3’), 6.36 (d, J=7.4 Hz, 1H, H-1’), 7.25 (s, 1H, H-6), 8.34 (br, 1H, NH). 13CNMR (100 MHz, CDCl3) δ (ppm): 6.5 (SeCH3), 12.5 (i-Pr), 12.6 (CH3), 12.7, 13.0, 13.9, 17.0,
17.1, 17.3, 17.4 (i-Pr), 49.9 (C-2’), 60.0 (C-5’), 73.7 (C-3’), 83.5 (C-4’), 84.5 (C-1’), 110.5 (C-5),
135.6 (C-6), 150.3 (C-2), 163.4 (C-4). HRMS (ESI): C23H42N2O6SeSi2; [M+Na]+: 601.1631 (calc.
601.1644).

5-methyl-2’-methylseleno-arabinouridine (2.6) Compound 2.5 (1 g, 1.8 mmol) was
dissolved in 10 mL anhydrous THF, and treated with 3HF·Et3N (0.29 mL, 1.8 mmol) at 40 oC for
2 h. The mixture was evaporated to dryness, and the residue was purified by flash column
chromatography on silica gel (5% MeOH in methylene chloride) to afford pure product 2.6 (597
mg, 99%) as white solid. 1H-NMR (400 MHz, DMSO) δ (ppm): 1.77 (d, J=1.0 Hz, 3H, CH3), 1.99
(s, 3H, SeCH3), 3.61-3.65 (m, 3H, H-2’, H-4’, H-5’), 3.74 (dd, J1=5.0 Hz, J2=9.5 Hz, 1H, H-5’),
4.11 (dd, J1=6.6 Hz, J2=14.8 Hz, 1H, H-3’), 5.15 (t, J=5.0 Hz, 1H, 5’-OH), 5.67 (d, J=5.9 Hz, 1H,
3’-OH), 6.23 (d, J=7.2 Hz, 1H, H-1’), 7.67 (d, J=0.7 Hz, 1H, H-6), 11.30 (s, 1H, NH). 13C-NMR
(100 MHz, DMSO) δ (ppm): 5.2 (SeCH3), 12.7 (CH3), 49.9 (C-2’), 59.7 (C-5’), 73.9 (C-3’), 84.8
(C-1’), 85.1 (C-4’), 108.9 (C-5), 137.1 (C-6), 150.9 (C-2), 164.1 (C-4). HRMS (ESI):
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C11H16N2O5Se; [M+Na]+: 359.0018 (calc. 359.0122). 1H-13C HSQC, 1H-13C HMBC and 1H-1H
COSY (Appendix D.1).

5’-O-(4,4’-dimethoxytrityl)-5-methyl-2’-methylseleno-arabinouridine

(2.7)

Compound 2.6 (500 mg, 1.5 mmol) was dried over high vacuum and co-evaporated with anhydrous
pyridine (2 x 10 mL). Then, the starting material was dissolved in 15 mL anhydrous pyridine and
cooled by ice bath, followed by the treatment of dimethoxytrityl chloride (DMTrCl) (542 mg, 1.6
mmol) under argon. The reaction was warmed up to room temperature and stirred for 2 h. Then
the solvent was removed under vacuum, the residue was dissolved in 30 mL methylene chloride.
The organic solution was washed with water (20 mL), brine (30 mL), dried over MgSO4 (s),
followed by filtration and evaporation. The crude product was purified by silica gel
chromatography (3% MeOH in methylene chloride with 1% Et3N) to afford the desired product
2.7 (851 mg, 89%) as white solid. 1H-NMR (400 MHz, CDCl3) δ (ppm): 1.61 (s, 3H, 5-CH3), 2.09
(s, 3H, SeCH3), 2.66 (d, J=4.1 Hz, 1H, 3’-OH), 3.48 (dd, J1=3.8 Hz, J2=10.7 Hz, 1H, H-5’), 3.57
(dd, J1=3.3 Hz, J2=10.8 Hz, 1H, H-5’), 3.61 (dd, J1=7.3 Hz, J2=8.3 Hz, 1H, H-2’), 3.81 (s, 6H,
OCH3), 3.88 (dt, J1=3.6 Hz, J2=6.1 Hz, 1H, H-4’), 4.30 (td, J1=4.0 Hz, J2=7.9 Hz, 1H, H-3’), 6.41
(d, J=7.2 Hz, 1H, H-1’), 6.85-6.87 (m, 4H, aromatic), 7.25-7.46 (m, 10H, aromatic, H-6), 8.75 (br,
1H, NH).
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C-NMR (100 MHz, CDCl3) δ (ppm): 6.3 (SeCH3), 12.1 (5-CH3), 50.4 (C-2’), 55.3

(OCH3), 61.8 (C-5’), 75.4 (C-3’), 82.5 (C-4’), 85.2 (Ar-C), 86.8 (C-1’), 110.4 (C-5), 113.3, 127.1,
128.0, 128.2, 130.1, 135.4, 135.5 (Ar-C), 135.8 (C-6), 144.4 (Ar-C), 150.4 (C-2), 158.7 (Ar-C),
163.7 (C-4). HRMS (ESI): C32H34N2O7Se; [M+Na]+: 661.1431 (calc. 661.1429).
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3’-O-(2-cyanoethyl-N,N-diisopropylphosphoramidite)-5’-O-(4,4’-dimethoxytrityl)-5methyl-2’-methylseleno-arabinouridine (2.8) The starting material 2.7 (500 mg, 0.8 mmol) was
dried under high vacuum and dissolved in 5 mL anhydrous CH2Cl2. To the solution,
dimethylethylamine (0.5 mL, 4.8 mmol) was injected, followed by the addition of the 2-cyanoehtyl
N,N-diisopropylchlorophosphoramidite (0.2 mL, 0.8 mmol). The reaction mixture was stirred at
room temperature under dry argon for 1 h. Then, the solvent was evaporated under reduced
pressure. The residue was re-dissolved in 2 mL CH2Cl2 and precipitated in 400 mL hexane under
vigorous stirring. The hexane solution was then decanted carefully, and the crude product was
further purified by silica gel chromatography (30% ethyl acetate in CH2Cl2 containing 1%
dimethylethylamine). The product was precipitated in hexane (400 mL) again, and the precipitate
was re-dissolved in CH2Cl2 and evaporated to afford the desired pure product 2.8 (542 mg, 81%)
as a white foam. HRMS (ESI): C41H51N4O8PSe; [M+Na]+: 861.2525 (calc. 861.2507).
2.4.3

2’-Se-functionalized oligonucleotides synthesis and HPLC purification

All DNA oligonulceotides were synthesized by solid-phase synthesis (Figure 2.15) using
an ABI3400 DNA/RNA synthesizer on a 1 μmol scale. 2’-MeSe-5-methyl-arabinouridine
phosphoramidite was dried under high vacuum for 3 h and prepared as 0.1 M concentration
solution in anhydrous acetonitrile prior of use. Normal phosphoramidites purchasing from
Glenresearch were used for the synthesis of natural nucleosides. The coupling reaction was carried
out using a tetrazole solution (0.45 M) in acetonitrile with a coupling time of 300 seconds. All the
oligonucleotides were prepared in DMTr-On mode, followed by the cleavage from CPG solid
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support (beads) and the deprotection with concentrated ammonia solution under 55 oC overnight.
The volatile ammonias were evaporated on a speed-vac concentrator, and the remaining beads
were extracted with water (3 x 0.5 mL). The DNA oligonucleotides were analyzed and purified by
reversed-phase high performance liquid chromatography (RP-HPLC), flow rate 6 ml/min [buffer
A: 20mM triethylammonium acetate (TEAAc, pH 7.1) in water; buffer B: 20mM TEAAc (pH 7.1)
in 50% acetonitrile]. The HPLC analysis was performed with a linear gradient from buffer A to
100% buffer B in 20 min. The detritylation was performed by treatment of the oligonucleotide
with an acetic acid solution (pH 4.5) under 40 oC for 1 h. The DMTr-off oligonucleotides were
desalted by a Water C-18 column and purified again by RP-HPLC. Native RNAs were purchased
from Integrated DNA Technologies. The native, as well as the Se modified DNAs were
characterized by matrix assisted laser desorption/ionization-time of fight mass spectrometry
(MALDI-TOF MS).

Figure 2.15 Steps of DNA solid-phase synthesis
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2.4.4

UV-melting and CD experiments

The thermal denaturing experiments were performed on Cary 300 UV-Vis spectrometer
equipped with a six-sample cell changer and a temperature controller. the sample annealed by
heated to 85 oC for 2 min and slowly cooling down to 4 oC before data acquisition. Both denaturing
and annealing curves were acquired at 260 nm with 1 cm path length at heating or cooling rates of
0.5 oC/min and data interval of 0.5 oC. The samples (2 μM DNA duplexes) were dissolved in the
buffer of 350 mM NaCl, 10 mM NaH2PO4-Na2HPO4 (pH 6.8), 0.1 mM EDTA.
The circular dichroism (CD) experiments were performed on Jasco J-1500 spectrometer.
The samples (3 μM DNA duplexes) were dissolved in the buffer of 1 mM NaCl, 1 mM NaH2PO4Na2HPO4 (pH=7.0), 0.1 mM EDTA.
2.4.5

DNA and DNA/protein complex Crystallization

For the DNA crystallization by itself, the purified DNA oligonucleotides were heated to 80
o

C for 2 min, then cooled down slowly to room temperature. The Nucleic Acid Mini Screen Kit

(Hampton Research) was applied to screen the crystallization conditions room temperature using
the hanging-drop method by vapor diffusion. The concentrations of the native, Se modified DNAs
were adjusted to 1.0 mM in water for crystallization. During the crystallization screening process,
the DNA solution was mixed with crystallization buffer at 1:1 ratio (0.5 μL+ 0.5 μL) and
equilibrate against 500 μL of the 35% MPD (2-methyl-2,4-pentanediol) solution within a hangingdrop plate.
For the DNA/Bst DNA polymerase complex crystallization, the purified DNA
oligonucleotides (1 mM) were annealed by first heating to 80°C for 2 min, and then slowly cool
down to room temperature. The resulting DNA solution was mixed with the protein (final
concentration: 24 mg/mL) at 1:1 molar ratio. Co-crystallization of Se-DNA/Bst DNA polymerase
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was achieved by screening with the QIAGEN Classics Suite Kit (www.qiagen.com) using the
sitting-drop vapor diffusion method at 25°C, and the mixture #67 was found to be the best buffer
condition for the crystal growth. [Salt: 0.2 M Calcium acetate; Buffer: 0.1 M sodium cacodylate,
pH 6.5; precipitant: 18% (w/v), PEG 8000].
2.4.6

Diffraction data collection and structure refinement

Diffraction data were collected on beamline 8.2.1 of the ALS (Advanced Light Source) at
the Lawrence Berkeley National Laboratory. X-ray data were collected under a liquid-nitrogen
stream at 99 K. Each crystal was exposed for 0.5 second per image with 1o rotation and a total of
360 images were obtained. The data were integrated and scaled with the programs HKL2000 and
DENZO/SCALEPACK.81 The structures were solved by molecular replacement method using
Phaser82 within CCP4i83, 84. The resulting models were refined using REFMAC5.585 within
CCP4i83, 84. The DNA, protein, ions and water molecules were added and modeled using Coot86.
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3

2’-MeSe-ARABINOCYTIDINE MODIFICATION FACILITATES B-DNA CRYSTAL
GROWTH AND X-RAY STRUCTURE STUDY

3.1

Introduction
3.1.1

The difficulties of B-form DNA crystallography

It is important to study the structure of nucleic acids which reveals the mechanisms of
diseases, viral infections as well as cancers, and provides information for treatment and drug
design. X-ray crystallography is one of the most powerful and successful method to determine the
3D-structure. To get high-resolution data for X-ray diffraction and gain insight into the structure
details, large, well-ordered, single crystal is required. As mentioned in the general introduction
section, it is more difficult to form crystal for nucleic acids than for proteins due to the negatively
charged repetitive phosphate backbone repelling the crystal packing as well as the conformational
heterogeneity. It is even more challenging to get a B-DNA crystal due to the high salt condition
during the crystallization process which disfavoring the B-DNA duplex formation.
Besides the challenges in the crystallization, the phasing problem will need to be solved
before determining the 3D structure through X-ray crystallography. The selenium-atomderivatized nucleic acid (SeNA) method has been pioneered and developed to solve this problem25.
The selenium atom can be used as an anomalous scattering center for phase determination via
either multiple or single wavelength anomalous diffraction (MAD or SAD), which become a
powerful method to solve the phasing problem rationally.
3.1.2

Selenium modifications on cytidine

To explore the selenium modification on nucleic acids for structural and functional studies,
different modified cytidine and its DNA/RNA oligonucleotides have been synthesized. 5methylselenyl-cytidine and its corresponding DNA, mimicking the 5-methylcytosine (m5C), were

43

synthesized and determined.87 Virtually identical structure were observed for the Se-DNA and the
corresponding native, which is consistent with the thermostability studies, indicating the well
accommodation of the selenium functionality without perturbing the DNA duplex.
The synthesis of 2’α-MeSe-C modified DNA and RNA as well as the structure study have
also been reported88-90. To introduce the selenium functionality to the 2’-α-position, an indirect
method via conversion of the corresponding uridine derivative 4 was used due to the low yield
giving from the direct incorporation (Figure 3.1). The structure of modified DNAs and RNAs were
determined through X-ray diffraction with MAD phasing. The modified nucleotides exhibit same
3’-endo sugar pucker and had no effect on the stability of the duplexes in the UV melting study
which demonstrating that the 2’-selenium functionality is suitable for RNA and A-DNA
derivatization for X-ray crystallography. Further study using the T4 RNA ligase successfully ligate
the selenium-containing RNA shows the high flexibility of the selenium approach (Figure 3.2).89

Figure 3.1 Synthesis of 2’α-MeSe-C/U modified DNA and RNA
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Figure 3.2 Enzymatic ligation of 2’-Se-methyluridine and 2’-Se-methylcytidine derivatized
oligoribonucleotides with T4 RNA ligase
3.2

Results and discussion
3.2.1

Synthesis of 2’βSe-C phosphoramidite and oligonucleotides

In the very beginning, we try to directly synthesize the 2’-β-MeSe-modified cytidine
through activating the 2’-OH group and substituted with MeSe via a SN2 reaction. However, the
synthesis was unsuccessful with different protective and leaving groups (Scheme 3.1). A
computational study reveals that the selenium incorporation step has a much higher energy barrier
(3.2 kcal/mol) than the corresponding uridine derivative with same leaving group (Appendix A).
Therefore, to introduce the selenium functionality will need either extremely high temperature
which requires a highly stable base protective group giving deprotection problem later, or an
extremely active leaving group which may result in various side-reactions.

Scheme 3.1 Direct incorporation of selenium functionality into cytidine

45

Based on the computational results, we designed an indirect method via the synthesis of a
2’β-MeSe-modified uridine derivative and conversion of the corresponding uridine to cytidine
(Scheme 3.2). The 5’.3’-OH groups were protected with tetraisopropyldisilylene (TIPDS),
followed by the protection of 3-N with benzyloxymethyl acetal (BOM). The 2’-OH group was
activated with mesylate, then treated with sodium methylselenolate generating from the reduction
of dimethyldiselenide by sodium borohydride in THF. After the selenium incorporation, the BOM
group was deprotected through the treatment of BBr3 in hexane, followed by quenching with a
mixture of anhydrous isopropanol and triethylamine. To convert the 2’βMeSe-uridine to cytidine,
the 4-O was activated with phosphoryl chloride and triazole. The activated intermediate was then
treated with ammonia given the 2’βMeSe-cytidine derivative C7. After acetylation of the base, the
TIPDS group was remove by treated with triethylamine trihydrofloride at elevated temperature.
The 5’-OH group was then protected with trityl and converted to 2’-Se-cytidine phosphoramidite
by reacting with 2-cyanoethyl N,N-diisopropylchlorophosphoramidite in the presence of
dimethylamine in dry CH2Cl2.

Scheme 3.2 Synthesis of 2’-β-MeSe-cytidine phosphoramidite and DNA oligonucleotides.
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Several DNA oligonucleotides were synthesized via the solid-phase synthesis showing the
compatibility of 2’βSe-C phosphoramidite. The 2’-MeSe group was stable under mild I2 treatment
for the phosphite oxidation and trichloroacetic acid treatment for detritylation. Moreover, coupling
yields of the DNA solid-phase synthesis using this novel 2’βSe-C phosphoramidite were higher
than 95%. The result DNA oligonucleotides were analyzed and purified with reversed-phase
HPLC and characterized by MALDI-TOF (Table 3.1).
Table 3.1 MALDI-TOF analytical data of native and SeC-DNA oligonucleotides
Entry
Se-oligonucleotides
Measured (calcd) m/z
1
C-s1
[M]+: 3739.7 (3739.4)
Se
5’- CGCGAATTCGCG-3’
C117H149N46O70P11Se FW 3739.4
2
C-s2
[M]+: 3739.6(3739.4)
5’-CGSeCGAATTCGCG-3’
C117H149N46O70P11Se FW 3739.4
3
C-s3
[M]+: 3739.6 (3739.4)
Se
5’-CGCGAATT CGCG-3’
C117H149N46O70P11Se FW 3739.4
4
C-s4
[M]+: 3739.7 (3739.4)
Se
5’-CGCGAATTCG CG-3’
C117H149N46O70P11Se FW 3739.4
5
Native
[M]+: 3645.9 (3646.4)
5’-CGCGAATTCGCG-3’
C115H145N46O70P11 FW 3646.4
3.2.2

Thermostability and circular dichroism comparison of DNAs containing 2’βSeCytidine

The UV melting temperatures of the SeC-DNAs were measured to examine the impact of
the modification on the thermostability of the duplexes. The melting curves are shown in Figure
3.3. The melting temperatures indicate that the position of SeC is directly relate to the stability of
the DNA duplex. With the shift of the modification from terminal into the middle of the sequence,
the destabilization effect is getting stronger from 4.4 oC to 37 oC compared to the corresponding
native DNA (Table 3.2), which reveals that the SeC modification may interrupt the base pairing or
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packing of the DNA. Modification at the terminal cytidine give the smallest effect to the stability.
CD measurements were also conducted at room temperature, and the results suggest that the
modified DNAs still exhibit similar B-form conformation in the buffer solution as the native
(Figure 3.4). However, a significant increase in intensity at 280 nm indicates there is some
difference in the conformation comparing with the native DNA.

Figure 3.3 Normalized UV-melting curves of the native and SeC-DNAs
Table 3.2 UV-melting temperature of the native and SeC-DNAs
Entry

Sequence

Melting
temperature (℃)

ΔTm(℃)

native

5’-CGCGAATTCGCG-3’

64.4

-

C-s1

5’-SeCGCGAATTCGCG-3’

60.0

4.4

C-s2

5’-CGSeCGAATTCGCG-3’

43.4

21

C-s3

5’-CGCGAATTSeCGCG-3’

27.4

37

C-s4

5’-CGCGAATTCGSeCG-3’

58.9

5.5
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Figure 3.4 CD spectra comparison of SeC-DNAs with the corresponding native
3.2.3

B-DNA and DNA/BST complex crystallization studies

The crystallization of

Se

C-DNAs was examined to demonstrate the ability of Se-

modification strategy to facilitate crystal growth (Figure 3.5). For the crystallization of DNA by
itself, only the sequence with the SeC at the terminal of the sequence (C-s1) form crystals, which
is consistent with our UV-melting study since it has the smallest destabilization effect. However,
to our surprise, this modification greatly speeds up the crystal growth (Figure X.). The first crystal
formed within 3 hours. It only took 20 hours to form crystals in 20 different buffer conditions,
comparing to the native DNA which needs at least two weeks.
Moreover, the SeC-DNAs also co-crystallized with a fragment of DNA polymerase I from
Bacillus stearotherophilus. However, for the

Se

C-DNA/BST complex crystallization, opposite

results were observed. Only the oligonucleotides with the modification at the terminal cytidine (Cs1) do not form crystal with BST polymerase. The C-s2 forms the best crystal with BST protein
compared with other modified oligonucleotides (Figure 3.6).
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Figure 3.5 Pictures of crystals with SeC modification
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Figure 3.6 The rate comparison of crystal growth
3.2.4

Structure of SeC-DNA/Bacillus fragment complex

The X-ray diffraction was also performed for crystals of SeC-DNAs. However, poor
resolution was obtained for all SeC-DNAs. The structure determine with SeT modification (5’CGCGAATTCGCG-3’) may provide an explanation (Fig. 3.7). The terminal cytidine was
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surrounded by another two DNA molecules which could be affected by the 2’MeSe-modification
on the cytidine and given an irregular packing.

Figure 3.7 Packing of 2’SeT-modified DNAs (5’-CGCGAATTCGCG-3’)
The crystal structure of fragment DNA polymerase I from Bacillus stearotherophilus with
DNA modified with methylselenium group at the 2’-arabino position of cytidine was determined
at 2.00 Å resolution. The modified DNA accommodated very well in the DNA/protein complex
structure which is virtually identical to the corresponding native complex with a RMSD of 0.176Å
for all 4387 atoms (Figure 3.8). The 2’-MeSe functionalities can be undoubtedly recognized from
the electron density map. The data collection and structure refinement statistics are summarized in
Table 3.3.

Figure 3.8 Superimposed structure of the SeC-DNA/BST complex with the native complex
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Table 3.3 Crystallographic data collection and refinement statistics of SeC-DNA/BST complex
DNA #
Cs2/BST
Wavelength (Å)
1
50.0-2.00
Resolution range (Å)
(2.03-2.00)
Space group
P212121
Unit-cell a, b, c (Å)
86.3, 94.2, 105.9
α, β, γ (°)
90, 90, 90
Unique reflections
58840(2886)
Completeness (%)
100.0(100.0)
Rmerge (%)
6.7 (46.6)
I/σ(I)
24.1 (4.2)
R value (%)
18.5
Rfree (%)
21. 2
2
Average B value (Å )
27.6
R.m.s.d. bond length (Å) 0.012
R.m.s.d. bond angle (°)
1.72
3.3

Conclusion
In conclusion, we successfully synthesized the 2’-β-MeSe-Cytidine phosphoramidite and

its DNAs through the conversion of the modified uridine to cytidine. We also demonstrate the
solid-phase synthesis, deprotection, and purification of 2’-β-MeSe-Cytidine modified
oligonucleotides. In the thermostability study, we found that the position of the SeC modification
is crucial to the stability of the DNA duplex, which also affect the ability of the DNAs to form
crystal. Interestingly, the terminal modification greatly speeds up the B-DNA crystallization with
broader crystallization conditions compared to the native. The modified DNAs were also cocrystallized with a fragment of DNA polymerase I from Bacillus stearotherophilus. The
modification site was well accommodated in the DNA/Bst protein complex structure without
significantly perturb the global structure, which suggests its excellent compatibility for
protein/DNA complex structure study. This modification could be further exploited in structure
determination of B-DNA, quadruplex, i-motif as well as DNA/drug complexes.
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3.4

Experimental section
3.4.1

General

Most solvents and reagents were purchased from Sigma, Fluka, or Aldrich (p.a.) and used
without purification unless mentioned otherwise. Triethylamine (TEA) was dried over KOH (s)
and distilled under argon. When necessary, solid reagents were dried under high vacuum.
Reactions with compounds sensitive to air or moisture were performed under argon. Solvent
mixtures are indicated as volume/volume ratios. Thin layer chromatography (TLC) was run on
Merck 60 F254 plates (0.25 mm thick; Rf values in the text are for the title products), and
visualized under UV-light or by a Ce-Mo staining solution (phosphomolybdate, 25 g;
Ce(SO4)2·4H2O, 10 g; H2SO4, 60 mL, conc.; H2O, 940 mL) with heating. Flash chromatography
was performed using Fluka silica gel 60 (mesh size 0.040-0.063 mm) using a silica gel:crude
compound weight ratio of ca. 30:1. 1H, 13C and 2D-NMR spectra were recorded using Bruker 400
(400 MHz). All chemical shifts (δ) are in ppm relative to tetramethylsilane and all coupling
constants (J) are in Hz. High resolution (HR) MS were either obtained with electrospray ionization
(ESI) on a Q-TOFTM Waters Micromass at Georgia State University.
3.4.2

Synthesis protocol and characterization

3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐2’-methylseleno-arabinocytidine
(3.1) Phosphorus oxychloride (1.2 mL, 13.2 mmol) was added to a solution of 1,2,4-triazole (3.6
g, 52.8 mmol) in dry acetonitrile (30 mL) under argon. After stirring for 1 hr. at room temperature,
dry triethylamine (15 mL, 105.6 mmol) was injected. The reaction was stirred another hour, then
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the suspension was filtered directly into a pressure vessel containing compound 2.5 (2.5 g, 4.4
mmol) in dry acetonitrile (10 mL) under argon. Then the reaction was heated up to 90 oC and
stirred at that temperature overnight. After the reaction was complete, the solution was cooled to
50 oC and treated with concentrated NH3∙H2O(10 mL, 15 M). After stirring at 50 oC for 2 hr, the
reaction mixture was evaporated to approximate 15 mL before extraction with ethyl acetate (3 x
100 mL). The combined organic layer was washed with brine (100 mL) and dried over anhydrous
MgSO4 (s) before evaporation. The crude product was purified by silica gel chromatography (2 %
methanol in dichloromethane) to give desired product 3.1 (1.9 g, 75 %). 1H-NMR (400 MHz,
CDCl3) δ (ppm): 1.01-1.11 (m, 28H, 4×iPrSi), 2.03 (s, 3H, SeCH3), 3.70 (dd, J1=6.8 Hz, J2=8.1
Hz, 1H, H-2’), 3.76 (dt, J1=7.2 Hz, J2=3.3 Hz, 1H, H-4’), 4.05 (m, 2H, H-5’), 4.25 (t, J=7.7 Hz,
1H, H-3’), 5.74 (d, J=7.4 Hz, 1H, H-5), 6.44, (d, J=6.6 Hz, 1H, H-1’), 7.58 (d, J=7.4, 1H, H-6).
C-NMR (100 MHz, CDCl3) δ (ppm): 6.2 (SeCH3), 12.5, 12.9, 13.1, 13.8, 17.0, 17.1, 17.3, 17.4,

13

17.5 (i-Pr), 49.9 (C-2’), 61.2 (C-5’), 75.2 (C-3’), 83.6 (C-4’), 85.1 (C-1’), 94.1 (C-5), 141.5 (C-6),
156.0 (C-2), 165.6 (C-4). HRMS (ESI): C22H41N3O5SeSi2; [M+Na]+: 586.2769 (calc. 586.1648).
1

H-13C HSQC, 1H-13C HMBC and 1H-1H COSY (Appendix D.2).

N4-acetyl-3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐2’-methylselenoarabinocytidine (3.2) Compound 3.1 (1.3 g, 2.3 mmol) was dissolved in 20 mL THF followed by
the addition of triethylamine (2.6 mL, 18.4 mmol) in a pressure vessel. The mixture was then
treated with N,N-dimethyl-aminopyridine (DMAP, 281 mg, 2.3 mmol) and acetic anhydride (1.3
mL, 13.8 mmol) under argon. The reaction was heated up to 85 oC and stirred at that temperature
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overnight. After the reaction complete, MeOH (2 mL) was added to the mixture. The reaction was
stirred for another 20 min to consume the excess acetic anhydride. The solvents were evaporated
under reduced pressure and the residue was re-dissolved in ethyl acetate (100 mL). The organic
solution was washed with water (30 mL), brine (30 mL) and dried over anhydrous MgSO4 (s)
before evaporation. The crude product was purified by silica gel chromatography (1 % methanol
in dichloromethane) to give desired product 3.2 (1.3 g, 95 %). 1H-NMR (400 MHz, CDCl3) δ
(ppm): 1.05-1.13 (m, 28H, 4×iPrSi), 2.07 (s, 3H, SeCH3), 2.27 (s, 3H, CH3), 3.73 (dd, J1=6.7 Hz,
J2=8.7 Hz, 1H, H-2’), 3.76 (dt, J1=7.5 Hz, J2=3.0 Hz, 1H, H-4’), 4.09 (d, J=3.0, 2H, H-5’), 4.24
(t, J=8.1 Hz, 1H, H-3’), 6.47, (d, J=6.6 Hz, 1H, H-1’), 7.45 (d, J=7.5 Hz, 1H, H-5), 7.97 (d, J=7.5,
1H, H-6), 10.27 (br, 1H, NH).

13

C-NMR (100 MHz, CDCl3) δ (ppm): 6.7 (SeCH3), 12.5, 12.9,

13.1, 13.8, 17.0, 17.1, 17.3, 17.4 (i-Pr), 24.8 (COCH3), 49.8 (C-2’), 60.8 (C-5’), 74.1 (C-3’), 83.9
(C-4’), 85.8 (C-1’), 96.2 (C-5), 145.0 (C-6), 154.9 (C-2), 162.7 (C-4), 171.0 (COCH3). HRMS
(ESI): C24H43N3O6SeSi2; [M+H]+: 606.1866 (calc. 605.1934). 1H-13C HSQC (Appendix D.2).

N4-acetyl-3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐2’-methylselenoarabinocytidine (3.3) Compound 3.2 (1 g, 1.7 mmol) was dissolved in 10 mL anhydrous THF,
and treated with 3HF·Et3N (0.26 mL, 1.7 mmol) at 40 oC for 2 h. The mixture was evaporated to
dryness, and the residue was purified by flash column chromatography on silica gel (5% MeOH
in methylene chloride) to afford pure product 3.3 (609 mg, 99%) as white solid. 1H-NMR (400
MHz, DMSO-d6) δ (ppm): 1.88 (s, 3H, SeCH3), 2.11 (s, 3H, CH3), 3.59-3.75 (m, 4H, H-2’, H-4’,
H-5’), 4.09 (m, 1H, H-3’), 5.07 (t, J=5.3, 1H, OH-5’), 5.74 (d, J=5.4, 1H, OH-3’), 6.29, (d, J=6.4
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Hz, 1H, H-1’), 7.20 (d, J=7.4 Hz, 1H, H-5), 8.19 (d, J=7.5, 1H, H-6), 10.86 (s, 1H, NH). 13C-NMR
(100 MHz DMSO-d6) δ (ppm): 5.4 (SeCH3), 24.8 (COCH3), 50.1 (C-2’), 60.6 (C-5’), 75.0 (C-3’),
85.7 (C-4’), 86.4 (C-1’), 95.2 (C-5), 146.1 (C-6), 154.9 (C-2), 162.7 (C-4), 171.5 (COCH3). HRMS
(ESI): C12H17N3O5Se; [M+Na]+: 386.0223 (calc. 386.0231). 1H-13C HSQC, 1H-13C HMBC and
1

H-1H COSY (Appendix D.2).

N4-acetyl-5’-O-(4,4’-dimethoxytrityl)-2’-methylseleno-arabinocytidine

(3.4)

Compound 3.3 (420 mg, 1.2 mmol) was dried over high vacuum and co-evaporated with anhydrous
pyridine (2 x 10 mL). Then, the starting material was dissolved in 15 mL anhydrous pyridine and
cooled by ice bath, followed by the treatment of dimethoxytrityl chloride (DMTrCl) (432 mg, 1.3
mmol) under argon. The reaction was warmed up to room temperature and stirred for 2 h. Then
the solvent was removed under vacuum, the residue was dissolved in 30 mL methylene chloride.
The organic solution was washed with water (20 mL), brine (30 mL), dried over MgSO4 (s),
followed by filtration and evaporation. The crude product was purified by silica gel
chromatography (3% MeOH in methylene chloride with 1% Et3N) to afford the desired product
3.4 (718 mg, 90%) as white solid. 1H-NMR (400 MHz, CDCl3) δ (ppm): 1.97 (s, 3H, SeCH3), 2.25
(s, 3H, CH3), 3.50 (dd, J1=4.4 Hz, J2=10.7 Hz, 1H, Ha-5’), 3.57 (dd, J1=3.4 Hz, J2=10.7 Hz, 1H,
Hb-5’), 3.83 (s, 6H, OCH3), 3.94 (t, J=6.4 Hz, 1H, H-2’), 4.02-4.05 (m, 1H, H-4’), 4.28 (t, J=6.2,
1H, H-3’), 6.54, (d, J=6.2 Hz, 1H, H-1’), 6.88 (d, J=8.8, 4H, Ph), 7.27-7.36 (m, 8H, Ph, H-5), 7.45
(d, J=7.4 Hz, 2H, Ph), 8.16 (d, J=7.5, 1H, H-6), 9.32 (br, 1H, NH). 13C-NMR (100 MHz, CDCl3)
δ (ppm): 6.4 (SeCH3), 24.9 (COCH3), 50.5 (C-2’), 53.4 (DMTr), 55.3 (OCH3), 62.1 (C-5’), 75.6
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(C-3’), 83.6 (C-4’), 86.9 (C-1’), 96.2 (C-5), 113.3 (DMTr), 127.1, 128.0, 128.2, 130.1, 135.5,
144.4 (DMTr), 145.3 (C-6), 155.6 (C-2), 158.7 (DMTr), 162.4 (C-4), 170.4 (COCH3). HRMS
(ESI): C33H35N3O7Se; [M+Na]+: 688.1511 (calc. 688.1538).

N4-acetyl-3’-O-(2-cyanoethyl-N,N-diisopropylphosphoramidite)-5’-O-(4,4’dimethoxytrityl)-2’-methylseleno-arabinocytidine (3.5) The starting material 3.4 (240 mg, 0.4
mmol) was dried under high vacuum and dissolved in 2 mL anhydrous CH2Cl2. To the solution,
dimethylethylamine (0.2 mL, 2.4 mmol) was injected, followed by the addition of the 2-cyanoehtyl
N,N-diisopropylchlorophosphoramidite (80 μL, 0.4 mmol). The reaction mixture was stirred at
room temperature under dry argon for 1 h. Then, the solvent was evaporated under reduced
pressure. The residue was re-dissolved in 2 mL CH2Cl2 and precipitated in 400 mL hexane under
vigorous stirring. The hexane solution was then decanted carefully, and the crude product was
further purified by silica gel chromatography (20-30% ethyl acetate in CH2Cl2 containing 1%
dimethylethylamine). The product was precipitated in hexane (400 mL) again, and the precipitate
was re-dissolved in CH2Cl2 and evaporated to afford the desired pure product 3.5 (260 mg, 75%)
as a white foam. HRMS (ESI): C42H52N5O8PSe; [M+Na]+: 887.8305 (calc. 887.8285).
3.4.3

Solid-phase synthesis of SeC-DNA oligonucleotides

All DNA oligonulceotides were synthesized by solid-phase synthesis using an ABI3400
DNA/RNA synthesizer on a 1 μmol scale. 2’-MeSe-arabinocytidine phosphoramidite was dried
under high vacuum for 3 h and prepared as 0.1 M concentration solution in anhydrous acetonitrile
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prior of use. Normal phosphoramidites purchasing from Glenresearch were used for the synthesis
of natural nucleosides. The coupling reaction was carried out using a tetrazole solution (0.45 M)
in acetonitrile with a coupling time of 300 seconds. All the oligonucleotides were prepared in
DMTr-On mode, followed by the cleavage from CPG solid support (beads) and the deprotection
with concentrated ammonia solution under 55 oC overnight. The volatile ammonias were
evaporated on a speed-vac concentrator, and the remaining beads were extracted with water (3 x
0.5 mL). The DNA oligonucleotides were analyzed and purified by reversed-phase high
performance liquid chromatography (RP-HPLC), flow rate 6 ml/min [buffer A: 20mM
triethylammonium acetate (TEAAc, pH 7.1) in water; buffer B: 20mM TEAAc (pH 7.1) in 50%
acetonitrile]. The HPLC analysis was performed with a linear gradient from buffer A to 100%
buffer B in 20 min. The detritylation was performed by treatment of the oligonucleotide with an
acetic acid solution (pH 4.5) under 40 oC for 1 h. The DMTr-off oligonucleotides were desalted
by a Water C-18 column and purified again by RP-HPLC. Native RNAs were purchased from
Integrated DNA Technologies. The native, as well as the Se modified DNAs were characterized
by matrix assisted laser desorption/ionization-time of fight mass spectrometry (MALDI-TOF MS).
3.4.4

UV-melting and CD measurements

The thermal denaturing experiments were performed on Cary 300 UV-Vis spectrometer
equipped with a six-sample cell changer and a temperature controller. the sample annealed by
heated to 85 oC for 2 min and slowly cooling down to 4 oC before data acquisition. Both denaturing
and annealing curves were acquired at 260 nm with 1 cm path length at heating or cooling rates of
0.5 oC/min and data interval of 0.5 oC. The samples (2 μM DNA duplexes) were dissolved in the
buffer of 350 mM NaCl, 10 mM NaH2PO4-Na2HPO4 (pH 6.8), 0.1 mM EDTA.
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The circular dichroism (CD) experiments were performed on Jasco J-1500 spectrometer.
The samples (3 μM DNA duplexes) were dissolved in the buffer of 1 mM NaCl, 1 mM NaH2PO4Na2HPO4 (pH=7.0), 0.1 mM EDTA.
3.4.5

DNA and DNA/protein complex crystallization

The purified DNA oligonucleotide was heated to 80 oC for 2 min, then cooled down slowly
to room temperature. The Nucleic Acid Mini Screen Kit (Hampton Research) was applied to screen
the crystallization conditions room temperature using the hanging-drop method by vapor diffusion.
The concentrations of the native, Se modified DNAs were adjusted to 1.0 mM in water for
crystallization. During the crystallization screening process, the DNA solution was mixed with
crystallization buffer at 1:1 ratio (0.5 μL+ 0.5 μL) and equilibrate against 500 μL of the 35% MPD
(2-methyl-2,4-pentanediol) solution within a hanging-drop plate.
For the DNA/Bst DNA polymerase complex crystallization, the purified DNA
oligonucleotides (1 mM) were annealed by first heating to 80°C for 2 min, and then slowly cool
down to room temperature. The resulting DNA solution was mixed with the protein (final
concentration: 24 mg/mL) at 1:1 molar ratio. Co-crystallization of Se-DNA/Bst DNA polymerase
was achieved by screening with the QIAGEN Classics Suite Kit (www.qiagen.com) using the
sitting-drop vapor diffusion method at 25°C, and the mixture #67 was found to be the best buffer
condition for the crystal growth. [Salt: 0.2 M Calcium acetate; Buffer: 0.1 M sodium cacodylate,
pH 6.5; precipitant: 18% (w/v), PEG 8000].
3.4.6

Diffraction data collection and structure determination

Diffraction data were collected on beamline 8.2.2 of the ALS (Advanced Light Source) at
the Lawrence Berkeley National Laboratory. X-ray data were collected under a liquid-nitrogen
stream at 99 K. Each crystal was exposed for 0.5 second per image with 1o rotation and a total of

59

180 images were obtained. The data were integrated and scaled with the programs HKL2000 and
DENZO/SCALEPACK.81 The structures were solved by molecular replacement method using
Phaser82 within CCP4i83, 84. The resulting models were refined using REFMAC5.585 within
CCP4i83, 84. The DNA, protein, ions and water molecules were added and modeled using Coot86.
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4

SYNTHESIS OF 2’-MeSe-ARABINOURIDINE FOR THE STRUCTURE STUDIES
OF DNA CONTAINING URACIL

4.1

Introduction
4.1.1

The biological significance of uracil in DNA

Uracil, naturally occurring in RNA, was also present in DNA in small quantities as a result
of either the spontaneous cytosine deamination or misincorporation of dUMP during DNA
replication. The biochemical, and structural studies reveal its biological and clinical significance.91
Spontaneous cytosine deamination is the hydrolysis reaction of cytosine to uracil which occurs
readily under physiological circumstances primarily in ss DNA regions, such as transcription
bubbles or replication forks, producing 100-500 uracil residues per day, per cell.92 By replacing
the cytosine with uracil, the deamination will lead to U:G mispairing which is highly mutagenic.
Mammalian cells contain four main uracil-DNA glycosylases (UNGs), which is the machinery for
repair of C deamination, recognizing and excising the uracil from the genome and generating an
abasic (AP) site.93, 94 Compared to cytosine deamination, the misincorporation of dUMP in the
place of dTMP in replication is the predominant source of uracil in DNA resulting in U:A pairing
which is not directly mutagenic, but may be cytotoxic. The uracil can still be recognized and
removed by UNGs and formed an abasic site which is mutagenic and will increase the level of
DNA strand breaks leading to cell death.95, 96 Study shows that the aberrant uracil incorporation
leads to cytotoxicity by inhibiting the thymidylate biosynthesis via inhibition of thymidylate
synthase (TS) which is an important target of several anticancer drugs exhibiting significance in
clinic studies.97 Uracil could also be introduced into DNA by enzymatic deamination of cytosine
in the Ig locus of B-cells which is important for diversification of antibodies after antigen
exposure.98
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The study of uracil in DNA could also reveals the evolution of DNA by answering the
question that why the nature chooses thymine instead of uracil. DNA replaces RNA because of its
superior information-storage capacity took place in two steps as suggested by modern biochemical
pathways.99, 100 The first step is the replacement of ribose with deoxyribose, followed by the
replacement of uracil with thymine. The tinkering nature of the evolution provide an explanation
that the replacement of uracil driven by the occasional removal of U opposite A by the protoUNG/MUG solved the cytosine deamination problem which results in U:G mispairs.101 The greater
photochemical mutation resistance of thymine could be another reason which making the genetic
message more stable.102 This explanation was further supported by the facts that the only different
base between DNA and RNA is the photosensitive one and the thymine is only in DNA which has
a requirement for long-term stability. However, the final answer to this question still requires more
fundamental studies.
4.1.2

Structural biology studies of DNA containing Uracil

X-ray crystallography is one of the most powerful methods in structural biology which
provide insight into the structure of DNA containing uracil and could further facilitate the
biomolecular mechanistic research, such as the human uracil-DNA glycosylase, and drug
discovery. The DNA of the Bacillus subtilis transducing bacteriophage PBS2 containing uracil in
the place of thymine and the structure was determined by X-ray diffraction which indicates that
the substitution of uracil for thymine has no major effect on the overall structure.103 The structure
studies of human UNG bound to DNA containing uracil reveals the extrahelical base recognition
and a catalytic mechanism for hydrolytic base excision.104-106 Further study indicates that the basepair dynamics plays a critical role in the genome-wide search for uracil by UNG which is initiated
by thermally induced opening of T:A and U:A base pairs.107 Another structure study of archaeal

62

DNA polymerases suggests its ability to recognize the uracil in DNA and stall replication on
encountering the pro-mutagenic base.108 However, the uracil recognition capability is limited to
the archaea, not occurring with bacteria and eukarya.109
4.1.3

Selenium modifications on uridine

4.1.3.1 2’-MeSe-U for A-form DNA crystallization
As mentioned previously, selenium functionality has been successfully introduced into
different position of uridine and incorporated into oligonucleotides to solve the phase problem for
nucleic acid crystallography through multiwavelength anomalous dispersion (MAD) or singlewavelength anomalous dispersion (SAD). The synthesis of 2’-selenium uridine analogues and the
oligonucleotides including DNA as well as RNA were reported by Du and Teplova et al. in 2002
(Scheme 4.1).37, 77 The 2’-α-position selenium modification retains the 3’-endo sugar puckering of
A-form DNA and RNA molecules. The crystal structure shows that the methylselenium moiety is
point to the minor groove of the duplex and the selenium-derivatized DNA exhibit virtually
identical conformation to the corresponding native without alter the A-DNA duplex geometry or
the minor groove hydration significantly (Figure 4.1).

Scheme 4.1 The synthesis of 2’-MeSe-uridine phosphoramidite
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Figure 4.1 global structure and electron density map of the decamer DNA duplex (1.3 Å, PDB
ID: 1MA8) [d(GCGTA)SeUd(ACGC)]2
4.1.3.2 2-Se modified U/T and their oligo crystal structure
To study the high fidelity of base pairing in both DNA and RNA, 2-selenium modified
thymidine and uridine was synthesized and incorporated into oligonucleotides (Scheme 4.2).27, 28
Both the X-ray crystal structure of Se-DNA (5’-G-2’MeSedU-G-2SeT-ACAC-3’)2 and Se-RNA r(5’GUAUA-2SeU-AC-3’)2 were solved by molecular replacement at high resolution (1.58 Å, 2.2 Å
respectively) (Figure 4.2). The results indicate that 2-Se-modified DNA/RNA has very similar
structure to the corresponding native. And the 2-Se-substitution enhanced the base pair fidelity by
further discouraging the T/C and T/G or U/G wobble pair in DNA and RNA respectively, but
without alter the native base pairing and overall duplex structure significantly. The steric hindrance
introduced by the bulky Se atom and the electronic effect, inability of forming a stable hydrogen
bond, are main factors responsible for the discrimination against wobble pair, hence increasing the
base pair recognition. Theoretical studies including quantum mechanics calculation, molecular
dynamics simulation and free-energy perturbation simulation further confirmed the experimental
conclusions.110 The free-energy calculation indicates that both the disfavored hydrogen bonding
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interaction and the unfavorable solvent entropic contribution lead to the high specificity of the 2Se-T/A pair.

Scheme 4.2 Synthesis of 2-Se-U/T modified DNA and RNA

Figure 4.2 A. SeT-DNA; B. the superimpose comparison of one SeU-RNA duplex (red; PDB ID:
3S49) with its native counterpart (cyan; PDB ID: 246D).
4.1.3.3 4-Se-uridine and its RNA crystal structure
Subsequently, Sheng et al. reported the synthesis of 4-Se-uridine and Se-RNA to probe the
U·U and U/A base pair.111 The Se-modified RNA duplexes r(5’-U-4SeU-CGCG-3’)2 and r(5’GUG-4SeU-AAC-3’)2 formed yellow crystals, and the structures were determined via SAD and
molecular replacement (Figure 4.3). The Se-derivatized and native structure are virtually identical
based on the crystal structure and thermostability studies which implies the RNA flexibility to
accommodate the large Se atom. The comparison of the Se-modified and native structure also
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suggested a stronger stacking interaction between Se-nucleobase to 3’-cytosine which can
strengthen the RNA duplexes. The decrease of H-bonding in U/A pair by 4-Se modification of
uridine was compensated by the base-stacking increase which may also increase the duplex
junction thermostability. By introducing the probe to the RNA duplex junctions, the study reveals
that each Se atom contributed additional stabilization about 0.4-0.8 kcal/mol to the RNA duplex
due to the uracil stacking. Interestingly, color RNA was generated by a single Se-modification
which shifts the uridine UV spectrum over 100 nm.

Figure 4.3 crystal and structure of the 4-Se-U RNA hexamer, (5’-U-SeU-CGCG-3’)2
So far, several Se-modified uridines as well as their oligonucleotides have been
synthesized. Their structures were also determined by X-ray diffraction. However, all
modifications were limited to either A-form DNA or RNA where both of them containing the
northern sugar conformation. In order to investigate the structure of DNA containing uracil, the
modified uridine analogue needs to accommodate the southern sugar pucker conformation as well
as the B-form DNA geometry. To solve this problem, herein, we describe the first synthesis of 2’MeSe-arabinouridine phosphoramidite and its incorporation into DNA by solid-phase synthesis.
The 2’-β-position selenium modification retain the 2’endo sugar conformation and fit to the B-
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form DNA geometry. The X-ray crystal structure of the Se-DNA was determined at a resolution
of 1.25 Å and the Se-derivatized structure was virtually identical to the native one.
4.2

Results and discussion
4.2.1

The synthesis of 2’MeSe-arabinouridine phosphoramidite and DNA oligos

The synthesis of 2’-MeSe-arabinouridine phosphoramidite (Scheme 4.3) is similar to the
synthesis of corresponding selenium modified thymidine (Chapter 2, Section 2.4.2). The 5’,3’hydroxyl groups of the uridine were protected with tetraisopropyldisilylene (TIPDS), followed by
the protection of 3-N with benzyloxymethyl acetal (BOM). To introduce the methylseleno group,
the 2’-OH group was activated with mesylate. Then, dimethyldiselenide was dissolved in
anhydrous THF and treated with n-butyllithium at -78 oC to generate the MeSe nucleophile. The
activated nucleoside U4 was dissolved in anhydrous THF and injected into the reaction at 60 oC
which is lower than the selenium incorporation of corresponding thymidine derivative indicating
a lower energy barrier of the reaction. This result is consistent with the computational study of the
transition state and activation energy of the methylseleno group incorporation for uridine,
thymidine, cytidine as well as 5-F-uridine (Appendix A.). After the selenium incorporation, the
BOM group was deprotected by treated with BBr3 under -78 oC in anhydrous toluene followed by
carefully quenching the reaction with a mixture of triethylamine (TEA) and i-PrOH (v/v, 1:1).
Only treated with TEA will reproduce the starting material. In the meanwhile, it is important to
use anhydrous i-PrOH due to the nucleophilic protic solvent, such as MeOH or water, can serve
as a nucleophile to substitute the MeSe group which was also activated by BBr3 (Scheme 4.4). The
compound U6 was treated with 3HF∙TEA to remove the TIPDS group and the 5-OH was
selectively protected with the DMTr group. Finally, the 2’-Se-arabinouridine U8 was converted to
corresponding phosphoramidite U9 in 90% yield.

67

Scheme 4.3 Synthesis of 2’-MeSe-arabinouridine phosphoramidite

Scheme 4.4 Deprotect BOM group and quench the reaction with a mixture of TEA and iPrOH
The phosphoramidite U9 was incorporated into DNA oligos through solid-phase synthesis
with phosphoramidites containing standard base protection. The synthesized DNA oligo was
cleaved off the solid support and fully deprotected by treating with concentrated ammonia at 55
o

C for 5 h, followed by the reverse-phase HPLC purification. Table 4.1 show the MALDI-TOF

MS analysis of all the purified DNA oligo.
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Table 4.1 MALDI-TOF MS Data of SeU-DNAs
Entry Se-oligonucleotides
Measured (calcd) m/z
dU-s1
2’Se
5’-CGCGAA UUCGCG-3’
+
1
[M]
: 3711.2 (3711.3)
C115H145N46O70P11Se FW
3711.3
dU-s2
2’Se
5’-CGCGAAU UCGCG-3’
+
2
[M] : 3710.8 (3711.3)
C115H145N46O70P11Se FW
3711.3
U-s1
2’Se
5’-CGCGAA UTCGCG-3’
+
3
[M] : 3725.1 (3725.4)
C116H147N46O70P11Se FW
3725.4
U-s2
2’Se
5’-CGCGAAT UCGCG-3’
+
4
[M]
: 3725.4 (3725.4)
C116H147N46O70P11Se FW
3725.4
Native 1
+
5’-CGCGAAUUCGCG-3’
5
[M+H] : 3617.6 (3617.6)
C114H143N46O70P11 FW 3616.6
Native 2
+
5’-CGCGAAUTCGCG-3’
6
[M+H] : 3633.3 (3633.4)
C115H145N46O70P11 FW 3632.4
Native 3
+
5’-CGCGAATUCGCG-3’
7
[M+H] : 3633.0 (3633.4)
C115H145N46O70P11 FW 3632.4
4.2.2

Thermostability studies

Two single modified Dickerson-Drew dodecamer were synthesized for the UV melting
experiment to study the impact of 2’-MeSe-arabino-dU on duplex thermal stability. With the
modification, about 8 oC drop in melting temperature were observed compared with the
corresponding native DNA suggesting that the Se-modified uridine destabilized the DNA duplex
(Table 4.2). This effect may come from the interaction between the methyl group on selenium with
nucleobases based on our structure study (Figure 4.4). Changing the position of the modified
uridine shows similar destabilization.
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Table 4.2 Melting temperature of Native and SeU-DNA duplexes
Melting
Entry
Sequence
temperature (℃)
U-n1
5’-CGCGAAUTCGCG-3’
64.5
Se
U-s1
5’-CGCGAA UTCGCG-3’ 56.2
U-n2
5’-CGCGAATUCGCG-3’
64.4
Se
U-s2
5’-CGCGAAT UCGCG-3’ 56.4

Normalized Abs

1.0

ΔTm(℃)
8.3
8.0

U-n1
U-n2
U-s1
U-s2

0.5

0.0

20

40
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80

100

o

Temperature ( C)

Figure 4.4 Normalized UV melting curve
4.2.3

Structure determination

The determined crystal structure (1.25 Å resolution) of Se-DNA is superimposable to the
corresponding native structure (1.25 Å resolution) with same space group (P212121). The structure
reveals that the 2’-Se-arabino-furanose displays the 2’-endo sugar pucker and the 2’-methylseleno
group is in the major groove of the B-DNA duplex. The Se-modified and the native structures are
also virtually identical with a RMSD of 0.155Å for all 430 atoms which support that the
incorporation of 2’-MeSe-arabinothymidine does not alter the global structure of the complex
(Figure 4.5, left). 2’-SeMe-arabino-dU/dA base pair is also superimposable over native U/A base
pair (Figure 4.5, right). The data collection and structure refinement statistics are summarized in
Table 4.3.
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Figure 4.5 Superimposed global and local structure of SeU-modified DNA as well as the
corresponding native
Table 4.3 Data collection and refinement statistics of SeU-DNA and the corresponding native
Data Collection
U-s2
Native 3
Wavelength (Å)
1
1
Resolution range (Å)
50 - 1.25
50 - 1.25
(1.27 – 1.25)
(1.27 - 1.25)
Space group
P 21 21 21
P 21 21 21
Unit-cell a, b, c (Å)
25.2, 39.8, 65.2
25.4, 39.7, 65.4
90, 90, 90
90, 90, 90
𝛂, 𝛃, 𝛄 (º)
Number of reflections
18820 (905)
17963 (854)
Completeness (%)
99.6 (98.5)
94.2 (91.0)
I/σ
32 (4.7)
73 (5.3)
R merge (%)
6.0 (46.1)
6.3 (49.9)
Refinement
Resolution range (Å)
34.00 - 1.25
39.94 - 1.25
Number of reflections
17603
17062
Completeness (%)
98.2
94.2
R value (%)
21.4
20.6
R free (%)
23.1
22.8
2
Average B value (Å )
15.4
20.0
Rms Bond Length (Å)
0.020
0.015
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Rms Bond Angle (º)

3.15

1.79

Interestingly, by comparing the DNA structure containing Se-modified uridine and
thymidine respectively, we found that the direction of the methyl group is different. For the 2’βSeU modified DNA, the methyl group is located between two nucleobase and is quite close to the
proximate cytosine (Figure 4.6, top). However, when comes to the 2’βSe-T, the methyl group is
pointed away from the nucleobase and has a long distance between either the uracil or the cytosine
(Figure 4.6, bottom). This effect may be explained by the electron deficient uracil attracting the
electron-rich methyl group which may contribute to the destabilization observed in the UV melting
studies for SeU modified instead of SeT modified DNA (Chapter 2, Section 2.2.2).

Figure 4.6 Local structures of the SeU-containing DNA [5’-CGCGAAT(SeU)CGCG]2 and SeTcontaining DNA [5’-CGCGAAT(SeT)CGCG]2.
Left, the distance between the methyl group and uracil as well as cytosine; Right, the distance
between the methyl group and thymine as well as cytosine.
In the meanwhile, we also compared the B-factors of the
normalized (Figure 4.7) by the same method using for

Se

Se

U-DNA and the native

T-DNA (Chapter 2, Section 2.2.5). In

contrast to SeT-DNA, instead of decrease, significant increase of the B-factor was observed on one
of the DNA strands at the phosphate group of the Se-U as well as the adjacent cytidine residue
compared to the native one which may also cause by the interaction between the methyl group and
the adjunct nucleobases. However, the similar average B-value of the SeU-DNA (15.4 Å2) and the
corresponding native one (20.0 Å2) indicating that the Se functionality does not change the global
molecular dynamics of the DNA duplex significantly.
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Figure 4.7 B-factor comparison between SeU-DNA and the native
4.3

Conclusion
In conclusion, we developed a route to synthesize the 2’-MeSe-arabinouridine analogues

and oligonucleotides containing selenium modification. High resolution structures were obtained
through X-ray crystallography for DNA duplex (1.25 Å). The structure shows that the 2’-βposition selenium derivatization retains the native 2’-endo conformation in the B-form DNA
duplex and the modification does not cause any significant structure perturbation. Compared to
the

Se

T-DNA, the electron deficient uracil attracts the methyl group on the selenium leading to

interaction with the adjunct nucleobases which may result in the drop of melting temperature as
well as the increase in local B-factors around the modified nucleoside. The incorporation of the
selenium functionality solving the phasing problem could help the structure study of DNAs
containing uracil.
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4.4

Experimental section
4.4.1

General

Most solvents and reagents were purchased from Sigma, Fluka, or Aldrich (p.a.) and used
without purification unless mentioned otherwise. Triethylamine (TEA) was dried over KOH (s)
and distilled under argon. When necessary, solid reagents were dried under high vacuum.
Reactions with compounds sensitive to air or moisture were performed under argon. Solvent
mixtures are indicated as volume/volume ratios. Thin layer chromatography (TLC) was run on
Merck 60 F254 plates (0.25 mm thick; Rf values in the text are for the title products), and
visualized under UV-light or by a Ce-Mo staining solution (phosphomolybdate, 25 g;
Ce(SO4)2·4H2O, 10 g; H2SO4, 60 mL, conc.; H2O, 940 mL) with heating. Flash chromatography
was performed using Fluka silica gel 60 (mesh size 0.040-0.063 mm) using a silica gel:crude
compound weight ratio of ca. 30:1. 1H, 13C and 31P-NMR spectra were recorded using Bruker-300
or 400 (300 or 400 MHz). All chemical shifts (δ) are in ppm relative to tetramethylsilane and all
coupling constants (J) are in Hz. High resolution (HR) MS were either obtained with electrospray
ionization (ESI) on a Q-TOFTM Waters Micromass at Georgia State University.
4.4.2

Synthesis protocol and characterization

3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)-uridine (4.1) Uridine (11 g, 49.1
mmol) was suspended in 250 mL dry pyridine with argon and the mixture was placed in an icebath. To the suspension, 1,3-dichloro-1,1,3,3-tetraisopropyl-disiloxane (12.8 mL, 58.9 mmol) was
added dropwise. Then the ice-bath was removed, and the reaction was stirred at room temperature
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for 5 h. After the reaction completed, 5 mL of Methanol was added. The solvent was evaporated
under reduced pressure and dissolved in methylene chloride (300 mL). The organic solution was
washed with HCl (3 M, 75 mL), saturated sodium bicarbonate (75 mL), water (100 mL), brine
(100 mL), dried over anhydrous MgSO4, and concentrated in vacuum to given 4.1 as white solid.
The product was used in the next step without further purification. 1H-NMR (400 MHz, CDCl3) δ
(ppm): 1.03-1.09 (m, 28H, 4×iPrSi ), 3.28 (br, s, 1H, OH), 4.01 (dd, J1=2.2 Hz, J2=13.1 Hz, 1H,
H-5’), 4.09 (d, J=8.4 Hz, 1H, H-4’), 4.18 (m, 2H, H-2’, H-5’), 4.38 (dd, J1=4.7 Hz, J2=8.6 Hz, 1H,
H-3’), 5.67 (d, ) 5.71 (d, J=8.1 Hz, 1H, H-1’), 7.66 (d, J=8.1 Hz 1H, H-6), 8.52 (br, s, 1H, NH).
1

H-NMR spectrum is identical to the literature112.

3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐N3-(benzyloxymethylacetal)uridine (4.2) Compound 4.1 (6.5 g, 13.4 mmol) was dissolved in 50 mL THF followed by the
addition of 1,8-Diazabicyclo(5.4.0)undec-7-ene (DBU, 4 mL, 26.8 mmol). The mixture was
treated with benzyl chloromethyl ether (2.8 mL, 20.1 mmol) and stirred at room temperature for 2
h. The solvent was evaporated under reduced pressure and washed with water (50 mL), brine (70
mL), dried over MgSO4 and concentrated. The residue was purified by silica gel chromatography
(25 % ethyl acetate in hexane) to give desired product 4.2 (6.6 g, 81 %). 1H-NMR (400 MHz,
CDCl3) δ (ppm): 1.02-1.10 (m, 28H, 4×iPrSi), 2.90 (br, s, 1H, OH), 4.00 (dd, J1=2.8 Hz, J2=13.2
Hz, 1H, H-5’), 4.10 (dt, J1=3.7 Hz, J2=8.5 Hz, 1H, H-4’), 4.13 (d, J=4.9 Hz, 1H, H-2’), 4.21 (dd,
J1=1.4 Hz, J2=13.3 Hz, 1H, H-5’), 4.34 (dd, J1=4.9 Hz, J2=8.8 Hz, 1H, H-3’), 4.72 (s, 2H,
CH2OCH2Ph), 5.47 (d, J=2.4 Hz, 2H, CH2OCH2Ph), 5.71 (d, J=8.2 Hz, 1H, H-5), 5.73 (s, 1H, H-
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1’), 7.38-7.26 (m, 6H, aromatic, H-6), 7.64 (d, J=8.2 Hz, 1H, H-6). 13C-NMR (100 MHz, CDCl3)
δ (ppm): 12.5, 12.9, 13.4, 16.8, 16.9, 17.0, 17.1, 17.3, 17.4 (i-Pr), 60.2 (C-5’), 68.9 (C-3’), 70.3
(CH2), 72.4 (CH2), 75.3 (C-2’), 81.9 (C-4’), 91.1 (C-1’), 101.5 (C-5), 127.7, 128.3 (Ar-C), 137.9
(Ar-C), 138.4 (C-6), 150.7 (C-2), 162.7 (C-4). HRMS (ESI): C29H46N2O8Si2; [M+Na]+: 629.1387
(calc. 629.2690). 1H-13C HSQC, 1H-13C HMBC and 1H-1H COSY (Appendix D.3).

2’-O-mesyl-3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐N3-(benzyloxymethyl
acetal)-uridine (4.3) Compound 4.2 (12.5 g, 20.6 mmol) was dissolved in 150 mL THF followed
by the addition of triethylamine (11.5 mL, 82.4 mmol). To the solution, methanesulfonyl chloride
(3.2 mL, 41.2 mmol) was added dropwise and the reaction was stirred at room temperature for 3
h. The solvent was evaporated under reduced pressure and dissolved in methylene chloride (150
mL). The organic solution was washed with water (50 mL) and brine (50 mL), dried over MgSO4
and concentrated. The residue was purified by silica gel chromatography (15 % ethyl acetate in
hexane) to give desired product 4.3 (12.7 g, 90 %). 1H-NMR (400 MHz, CDCl3) δ (ppm): 1.041.11 (m, 28H, 4×iPrSi), 3.28 (s, 3H, O3SCH3), 3.99 (dd, J1=2.3 Hz, J2=13.7 Hz, 1H, H-5’), 4.10
(dd, J1=1.9 Hz, J2=9.7 Hz, 1H, H-4’), 4.25-4.30 (m, 2H, H-3’, H-5’), 4.71 (s, 2H, CH2OCH2Ph),
4.97 (d, J=4.4 Hz, 1H, H-2’), 5.48 (m, 2H, CH2OCH2Ph), 5.72 (d, J=8.2 Hz, 1H, H-5), 5.79 (s,
1H, H-1’), 7.26-7.37 (m, 5H, aromatic), 7.74 (d, J=8.2 Hz, 1H, H-6). 13C-NMR (100 MHz, CDCl3)
δ (ppm): 12.6, 12.8, 12.9, 13.6, 16.8, 16.9, 17.2, 17.4 (i-Pr), 39.3 (O3SCH3), 59.0 (C-5’), 66.6 (C3’), 70.3 (CH2), 72.4 (CH2), 82.0 (C-4’), 82.8 (C-2’), 88.9 (C-1’), 101.9 (C-5), 127.6, 127.8, 128.3
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(Ar-C), 137.3 (C-6), 137.8 (Ar-C), 150.7 (C-2), 162.4 (C-4). HRMS (ESI): C30H48N2O10SSi2;
[M+H]+: 685.1212 (calc. 685.2646). 1H-13C HSQC and 1H-1H COSY (Appendix D.3).

3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐N3-(benzyloxymethylacetal)-2’methylseleno-arabinouridine (4.4) Me2Se2 (2.4 mL, 25.3 mmol) was dissolved in anhydrous
THF (25 mL) under argon. The solution was cooled to -78 oC in an acetone/dry ice bath followed
by the injection of n-BuLi (5 mL, 2.5 M in hexane, 12.6 mmol). The reaction was allowd to warm
up to room temperature slowly. Then, the starting material 4.3 (4.3 g, 6.3 mmol) was dissolved in
25 mL anhydrous THF and added into the solution. The reaction mixture was heated up to 65 oC
and stirred for 16 h. The solution was concentrated under reduced pressure and re-dissolved in
ethyl acetate (100 mL). The organic solution was washed with water (30 mL), brine (40 mL), dried
over MgSO4, and evaporated to dryness to afford crude product. The residue was then purified by
silica gel chromatography (10 % ethyl acetate in hexane) to give desired product 4.4 (3.0 g, 69.8
%) as white solid. 1H-NMR (400 MHz, CDCl3) δ (ppm): 1.03-1.11 (m, 28H, 4×iPrSi), 2.08 (s, 3H,
SeCH3), 3.64 (dd, J1=7.0 Hz, J2=10.1 Hz, 1H, H-2’), 3.76 (d, J=8.1 Hz, 1H, H-4’), 4.04 (dd, J1=2.7
Hz, J2=13.2 Hz, 1H, Ha-5’), 4.13 (dd, J1=1.7 Hz, J2=13.2 Hz, 1H, Hb-5’), 4.18 (dd, J1=8.6 Hz,
J2=9.7 Hz, 1H, H-3’), 4.68 (d, J=3.1 Hz, 2H, CH2OCH2Ph), 5.51 (s, 2H, CH2OCH2Ph), 5.75 (d,
J=8.2 Hz, 1H, H-5), 6.40 (d, J=6.9 Hz, 1H, H-1’), 7.28-7.37 (m, 5H, Ph), 7,58 (d, J=8.2 Hz, 1H,
H-6). 13C-NMR (100 MHz, CDCl3) δ (ppm): 6.7 (SeCH3), 12.5, 12.9, 13.0, 13.8, 17.0, 17.1, 17.2,
17.3, 17.5 (i-Pr), 50.1 (C-2’), 60.1 (C-5’), 70.2 (CH2), 71.8 (CH2), 72.9 (C-3’), 83.8 (C-4’), 85.5
(C-1’), 101.7 (C-5), 127.0, 127.7, 127.8, 128.3, 128.6 (Ar-C), 137.9 (Ar-C), 138.5 (C-6), 151.3
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(C-2), 162.7 (C-4). HRMS (ESI): C30H48N2O7SeSi2; [M+Na]+: 707.2105 (calc. 707.2063). 1H-13C
HSQC, 1H-13C HMBC and 1H-1H COSY (Appendix D.3).

3ʹ,5ʹ‐O‐(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)‐2’-methylseleno-arabinouridine
(4.5) Compound 4.4 (1.7 g, 2.5 mmol) was placed in a round bottom flask, purge with argon and
dissolved in 15 mL anhydrous toluene. The solution was cooled down to -78 oC by placing in a
dry ice-acetone bath. To the solution, BBr3 solution (3.8 mL, 1 M in hexane, 3.8 mmol) was
injected and the reaction was stirring at -78 oC for 1 h. Then, the reaction was quenched by adding
a mixture of triethylamine and anhydrous isopropanol (2 mL, 1:1, v/v), followed by the remove of
the dry ice-acetone bath. The solution was stirred at room temperature for another 1 h. The reaction
was concentrated to around 2 mL and diluted with 50 mL of ethyl acetate. The organic solution
was washed with water (30 mL). The water layer was then extracted with ethyl acetate (3 x 10
mL), and the combined organic layer was washed with brine (40 mL), dried over MgSO4 (s),
followed by filtration. The solvent was evaporated under reduced pressure to afford the crude
product. The residue was then purified by silica gel chromatography (15 % ethyl acetate in hexane)
to give desired product 4.5 (1.0 g, 70 %). 1H-NMR (400 MHz, CDCl3) δ (ppm): 1.05-1.12 (m,
28H, 4×iPrSi), 2.13 (s, 3H, SeCH3), 3.64 (dd, J1=7.0, J2=10.1 Hz, 1H, H-2’), 3.77 (dt, J1=2.4,
J2=8.1 Hz, 1H, H-4’), 4.05 (dd, J1=2.8, J2=13.2 Hz, 1H, Ha-5’), 4.13 (dd, J1=1.9, J2=13.2 Hz, 1H,
Hb-5’), 4.21 (dd, J1=8.3, J2=10.0 Hz, 1H, H-3’), 5.72 (dd, J1=2.0, J2=8.1 Hz, 1H, H-5), 6.39 (d,
J=7.0, 1H, H-1’), 7.59 (d, J=8.2 1H, H-6), 9.10 (br, 1H, NH).

13

C-NMR (100 MHz, CDCl3) δ

(ppm): 6.6 (SeCH3), 12.5, 12.9, 13.0, 13.8, 17.0, 17.1, 17.2, 17.3, 17.4 (i-Pr), 49.9 (C-2’), 60.1 (C-

78

5’), 73.1 (C-3’), 83.8 (C-4’), 84.8 (C-1’), 102.1 (C-5), 139.9 (C-6), 150.5 (C-2), 163.1 (C-4).
HRMS (ESI): C22H40N2O6SeSi2; [M-H]-: 563.1525 (calc. 563.1512). 1H-13C HSQC, 1H-13C
HMBC and 1H-1H COSY (Appendix D.3).

5-methyl-2’-methylseleno-arabinouridine (4.6) Compound 4.5 (1 g, 1.8 mmol) was
dissolved in 10 mL anhydrous THF, and treated with 3HF·Et3N (0.29 mL, 1.8 mmol) at 40 oC for
2 h. The mixture was evaporated to dryness, and the residue was quickly purified by a short flash
column chromatography on silica gel (5% MeOH in methylene chloride) to remove salt and used
for next step without further purification. HRMS (ESI): C10H14N2O5Se; [M-H]-: 320.9982 (calc.
320.9990).

5’-O-(4,4’-dimethoxytrityl)-5-methyl-2’-methylseleno-arabinouridine

(4.7)

Compound 4.6 (300 mg, 0.9 mmol) was dried over high vacuum and co-evaporated with anhydrous
pyridine (2 x 10 mL). Then, the starting material was dissolved in 15 mL anhydrous pyridine and
cooled by ice bath, followed by the treatment of dimethoxytrityl chloride (DMTrCl) (339 mg, 1.0
mmol) under argon. The reaction was warmed up to room temperature and stirred for 2 h. Then
the solvent was removed under vacuum, the residue was dissolved in 30 mL methylene chloride.
The organic solution was washed with water (20 mL), brine (30 mL), dried over MgSO4 (s),
followed by filtration and evaporation. The crude product was purified by silica gel
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chromatography (3% MeOH in methylene chloride with 1% Et3N) to afford the desired product
4.7 (505 mg, 90%) as white solid. 1H-NMR (400 MHz, CDCl3) δ (ppm): 2.13 (s, 3H, SeCH3), 2.66
(d, J=4.1 Hz, 1H, 3’-OH), 3.48 (dd, J1=3.8 Hz, J2=10.7 Hz, 1H, H-5’), 3.57 (dd, J1=3.3 Hz, J2=10.8
Hz, 1H, H-5’), 3.61 (dd, J1=7.3 Hz, J2=8.3 Hz, 1H, H-2’), 3.81 (s, 6H, OCH3), 3.88 (dt, J1=3.6 Hz,
J2=6.1 Hz, 1H, H-4’), 4.30 (td, J1=4.0 Hz, J2=7.9 Hz, 1H, H-3’), 5.72 (dd, J1=2.0, J2=8.1 Hz, 1H,
H-5), 6.41 (d, J=7.2 Hz, 1H, H-1’), 6.85-6.87 (m, 4H, Ph), 7.25-7.46 (m, 9H, Ph), 7.59 (d, J=8.2
1H, H-6), 8.95 (br, 1H, NH). 13C-NMR (100 MHz, CDCl3) δ (ppm): 6.6 (SeCH3), 50.4 (C-2’), 55.3
(OCH3), 61.8 (C-5’), 75.4 (C-3’), 82.5 (C-4’), 85.2 (Ar-C), 86.8 (C-1’), 102.5 (C-5), 113.3, 127.1,
128.0, 128.2, 130.1, 135.4, 135.5 (Ar-C), 139.8 (C-6), 144.4 (Ar-C), 150.4 (C-2), 158.7 (Ar-C),
163.7 (C-4). HRMS (ESI): C31H31N2O7Se; [M-H]-: 623.1298 (calc. 623.1296).

3’-O-(2-cyanoethyl-N,N-diisopropylphosphoramidite)-5’-O-(4,4’-dimethoxytrityl)-5methyl-2’-methylseleno-arabinouridine (4.8) The starting material 4.7 (680 mg, 1.1 mmol) was
dried under high vacuum and dissolved in 5 mL anhydrous CH2Cl2. To the solution,
dimethylethylamine (0.7 mL, 6.6 mmol) was injected, followed by the addition of the 2-cyanoehtyl
N,N-diisopropylchlorophosphoramidite (0.2 mL, 1.1 mmol). The reaction mixture was stirred at
room temperature under dry argon for 1 h. Then, the solvent was evaporated under reduced
pressure. The residue was re-dissolved in 2 mL CH2Cl2 and precipitated in 400 mL hexane under
vigorous stirring. The hexane solution was then decanted carefully, and the crude product was
further purified by silica gel chromatography (30% ethyl acetate in CH2Cl2 containing 1%
dimethylethylamine). The product was precipitated in hexane (400 mL) again, and the precipitate
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was re-dissolved in CH2Cl2 and evaporated to afford the desired pure product 4.8 (659 mg, 80%)
as a white foam. HRMS (ESI): C40H49N4O8PSe; [M+Na]+: 847.2376 (calc. 847.2351).
4.4.3

DNA oligo synthesis and purification

Solid-phase synthesis was used for All DNA oligonulceotides using an ABI3400
DNA/RNA synthesizer on a 1 μmol scale. 2’-MeSe-arabinouridine phosphoramidite was dried
under high vacuum for 3 h and prepared as 0.1 M concentration solution in anhydrous acetonitrile
prior of use. Normal phosphoramidites purchasing from Glenresearch were used for the synthesis
of natural nucleosides. The coupling reaction was carried out using a tetrazole solution (0.45 M)
in acetonitrile with a coupling time of 300 seconds. All the oligonucleotides were prepared in
DMTr-On mode, followed by the cleavage from CPG solid support (beads) and the deprotection
with concentrated ammonia solution under 55 oC overnight. The volatile ammonias were
evaporated on a speed-vac concentrator, and the remaining beads were extracted with water (3 x
0.5 mL). The DNA oligonucleotides were analyzed and purified by reversed-phase high
performance liquid chromatography (RP-HPLC), flow rate 6 ml/min [buffer A: 20mM
triethylammonium acetate (TEAAc, pH 7.1) in water; buffer B: 20mM TEAAc (pH 7.1) in 50%
acetonitrile]. The HPLC analysis was performed with a linear gradient from buffer A to 100%
buffer B in 20 min. The detritylation was performed by treatment of the oligonucleotide with an
acetic acid solution (pH 4.5) under 40 oC for 1 h. The DMTr-off oligonucleotides were desalted
by a Water C-18 column and purified again by RP-HPLC. Native RNAs were purchased from
Integrated DNA Technologies. The native, as well as the Se modified DNAs were characterized
by matrix assisted laser desorption/ionization-time of fight mass spectrometry (MALDI-TOF MS).

81

4.4.4

UV-metling studies

The thermal denaturing experiments were performed on Cary 300 UV-Vis spectrometer
equipped with a six-sample cell changer and a temperature controller. the sample annealed by
heated to 85 oC for 2 min and slowly cooling down to 4 oC before data acquisition. Both denaturing
and annealing curves were acquired at 260 nm with 1 cm path length at heating or cooling rates of
0.5 oC/min and data interval of 0.5 oC. The samples (2 μM DNA duplexes) were dissolved in the
buffer of 350 mM NaCl, 10 mM NaH2PO4-Na2HPO4 (pH 6.8), 0.1 mM EDTA.
4.4.5

DNA Crystallization

The purified DNA oligonucleotide was heated to 80 oC for 2 min, then cooled down slowly
to room temperature. The Nucleic Acid Mini Screen Kit (Hampton Research) was applied to screen
the crystallization conditions room temperature using the hanging-drop method by vapor diffusion.
The concentrations of the native, Se modified DNAs were adjusted to 1.0 mM in water for
crystallization. During the crystallization screening process, the DNA solution was mixed with
crystallization buffer at 1:1 ratio (0.5 μL+ 0.5 μL) and equilibrate against 500 μL of the 35% MPD
(2-methyl-2,4-pentanediol) solution within a hanging-drop plate. Crystals were formed within 2
weeks (Figure 4.8).

Figure 4.8 Crystal of SeU-DNA
4.4.6

Diffraction data collection and structure refinement

Diffraction data were collected on beamline 8.2.2 of the ALS (Advanced Light Source) at
the Lawrence Berkeley National Laboratory. X-ray data were collected under a liquid-nitrogen
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stream at 99 K. Each crystal was exposed for 0.5 second per image with 1o rotation and a total of
360 images were obtained. The data were integrated and scaled with the programs HKL2000 and
DENZO/SCALEPACK.81 The structures were solved by molecular replacement method using
Phaser82 within CCP4i83, 84. The resulting models were refined using REFMAC5.585 within
CCP4i83, 84. The DNA, protein, ions and water molecules were added and modeled using Coot86.
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5

TELLURIUM MODIFIED OLIGONUCLEOTIDES SYNTHESIS FOR CHARGE
TRANSPORT STUDY

5.1

Introduction
Beyond all doubt, nucleic acids are the most important biomolecules for all known forms

of life, which storing all genetic information and passing it from one generation to the next.
Extensive studies about nucleic acid reveals its structure, functions and properties113-115 and
stimulated the investigations of chemical modifications of nucleoside and nucleic acids which have
been widely applied to lots of areas such as pharmaceutics116,
asymmetric catalysis120,

121

117

, crystallography118,

119

,

and material science122. With the remarkable structural stability,

flexibility and its self-assembly properties, DNA has great potential as novel material in molecular
electronics, biosensing and signaling devices. With the continuous development of single molecule
break-junction technique, various attempts123-125 have been made to manipulate, control, and
modify a natural DNA for the request of both high conductivity and functional I-V characteristics.
As same group element of tellurium, selenium modifications was widely applied for protein
structure determination, by replacing the sulfur in methionine, in which the selenium can be used
as an ideal scattering centers for multiwavelength anomalous dispersion (MAD)126-128. The
selenium-derivatized nucleic acids (SeNA) was also achieve great success in 3D crystal structure
determination and selenium has been introduced to different positions of the ribose, the phosphate
backbone as well as the nucleobases (Scheme 5.1)118, 119, 129, 130. It is worth to mention that the
incorporation of 2’-selenium modified nucleoside into DNA oligo not only solved the phase
problem but also greatly facilitated the crystallization, especially because, compared with protein
crystallization, there are more challenge in nucleic acid crystallization due to the negatively
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charged repetitive phosphate groups. However, compared with selenium, the application of
tellurium in nucleic acid was still quite limited.

Scheme 5.1 Atom-specific selenium substitution of oxygen atoms in nucleic acids
5.1.1

Properties and applications of tellurium

Tellurium is a metalloid located in the group VI, also known as chalcogens, of the periodic
table following sulphur and selenium. Its properties and functions have been well studied and
shows multiple potential applications in different areas131. Tellurium has a larger radius (1.35 Å)
and a weaker electronegativity (2.0) in the comparison to sulphur (1.04 Å, 2.58) and selenium
(1.17Å, 2.55). The larger electrovalent and co-ordination sphere radius provide tellurium strong
metallic properties and result in weak covalent bonds with carbon and hydrogen132. Naturally
occurring tellurium containing a series of isotopes, including

120

Te (natural abundance 0.09%),

122

Te (2.55%), 123Te (0.89%), 124Te (4.74%), 125Te (7.07%), 126Te (18.84%), 128Te (31.74%) and

130

Te (34.08%)133, which result in a unique isotope pattern in mass spectrometry for Te-containing

compounds. Meanwhile, the diamagnetic nucleus

125

Te (spin 1/2) enables Te-NMR studies and

has wide chemical shifts ranging from -1400 ppm to 3400 ppm. Moreover, it also has excellent
sensitivity due to the high natural abundance (7.07%) compared with 13C (1.1%)134.
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5.1.2

Incorporation of tellurium into protein

In 1989, tellurium was successfully incorporated into protein in a tellurium-tolerant fungus
which was achieved by growing the Te-resistant fungi on a sulfur-free medium and extraordinary
high level of tellurium was detected135. Later, telluromethionine was reported to be selectively
incorporated into dihydrofolate reductase136. Further studies optimized the bioincorporation
technique of TeMet in to protein and provide a promising approach for X-ray structure study of
protein137. The absorption edge of tellurium is about 0.3Å, which indicates that it is not as suitable
as selenium (0.9795Å) as a scattering center in MAD experiment. But the ideal electronic and
atomic properties of tellurium for generating clear isomorphous signals make it a suitable heavyatom for isomorphous replacement without the need of synchrotron radiation132.
5.1.3

Tellurium in nucleic acids

The incorporation of Te into nucleic acid was also achieved in the past ten years. The first
2’-Te modified nucleoside was reported by Huang et al. in 2008138 and then successfully
incorporated into DNA oligo through solid-phase synthesis139. Furthermore, the Te functionality
was also incorporated to the 5-position of a pyrimidine and the crystal structure of modified TeDNA was determined140.

Scheme 5.2 Synthesis of 2’-phenyltelluro-nucleoside
5.1.3.1 2’-Te modification
The synthesis of 2’PhTe-modified was reported by Huang et al. (Scheme 5.3)139. TePh
functionality was successfully introduced into 2’-position of both uridine and ribo-thymidine with
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good yield. However, unlike the MeSe functionality89, 141-145, the 1’, 2’- and 2’, 3’-eliminations
was observed during Te functionalization when using sodium borohydride as reducing reagent at
room temperature (Scheme 5.2).

Scheme 5.3 Elimination reactions resulting from the 2’-TeMe functionality
To get the desired product X, a stronger reducing reagent and lower temperature (0 oC) was
applied together with crown ether (12-crown-4) to chelate the lithium ions to enhance the MeTe
reactivity. The desired product was obtained in 47 % yield with the 1’, 2’-elimination products as
the major byproduct. Both PhTe and MeTe modified nucleosides were incorporated into DNA
oligos by solid-phase synthesis through standard protocol88 and quantitative coupling yield was
achieved. A few of Te-DNAs was oxidized to telluxides during the solid-phase synthesis which
can be reduced by treating with diborane after the deprotection step (Scheme 5.3). It was found
that both methyltelluride and phenyltelluride functionalities was stable with the treatment of mild
acid and base during the deprotection and purification. Interestingly, under heating (50 oC) in the
presence of B2H6 or I2, 2’-TePh DNA undergoes 2’, 3’-elimination at the modification site and
generates the fragmented product. However, the 1’, 2’-elimination was observed for 2’-TeMe
DNA and creates the abasic product (Scheme 5.4).139 The decrease of the melting temperature was
observed during the UV melting study which probably caused by the perturbation introduced by
the bulky Te functionality (Figure 5.1).
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Scheme 5.4 Redox and fragmentation of 2’-Te nucleoside

Figure 5.1 UV melting studies of the native and 2’Te-DNAs
5.1.3.2 5-Te modification
In 2011, 5-PhTe modified nucleoside was successfully synthesized by applying the
lithium-halogen exchange reaction146 on a protected 5-iodo-2’-deoxyuridine140 and achieved
medium yield (64 %) (Scheme 5.5). The key steps of the reaction are the
deprotonation of the NH and the treatment with n-BuLi followed by the
addition of Ph2Te2. Elevated concentration of the reactant (0.15 - 0.18 M)
is necessary to avoid the generation of 6-PhTe isomer which is
inseparable. The synthesis of the corresponding phosphoramidite was followed the standard
protocol140 and applied to solid-phase synthesis. The results show that the PhTe functionality is

88

well compatible with the solid-phase synthesis condition, deprotection and purification. The UVthermal denaturation studies show similar stability between the Te-derivatized duplex and the
corresponding native which suggested that the bulky PhTe moiety is well accommodated and does
not significantly change the duplex structure.

Scheme 5.5 Synthesis of 5-phenyltelluro-2’-deoxyuridine
The Te-DNA crystal structure was also obtained by the same author by using 2’-Se
modification strategy147-150. The results revealing that Te-DNA has virtually identical global and
local structures as the corresponding native DNA (Figure 5.3)140. This result further confirms that
the Te-functionality does not cause significant perturbation. The Te-DNA was quite stable under
high temperature (90 oC) but it was found to be sensitive to X-ray irradiation. Partial cleavage of
Te-C bond was detected through MALDI-TOF-MS after X-ray irradiation. Due to the metallic
property of the tellurium atom, STM imaging studies show stronger topographic and current peaks
for Te-modified DNA duplex compared to the native one (Figure 5.4)140.
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Figure 5.2 Crystal photo of the Te-DNA octomer [5’-G(2’-SeMe-dU)G(TeT)ACAC-3]2

Figure 5.3 The global and local structures of the Te-DNA duplex

Figure 5.4 The STM images of the Te-modified DNA duplex
The Te-modified DNA and RNA are a promising strategy to investigate the structure and
function of nucleic acid. However, studies about this area are still quite limited and only a few
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papers published in last 10 years. 2’- and 5-position tellurium modified nucleoside has been
successfully synthesized, and both are compatible with the solid-phase synthesis, deprotection and
purification. The particular redox properties and selective elimination of the 2’-Te modified DNA
oligo could be useful in studying the DNA fragmentation and nucleobase damage. The location of
the Te functionality modification and the size of the protecting group directly affect the melting
temperature of the duplex which could be used as a useful strategy for detecting DNA and RNA
polymerization and catalysis. Furthermore, due to the metallic property of the tellurium atom, the
Te-modified DNA duplex become visible under STM which suggesting a promising strategy to
directly image DNA without structural perturbation. This will further help us accomplishing
mechanism and function studies or even making novel nano-electronic materials.
Herein, we report the synthesis of 5-PhTe and 5-PhSe thymidine modified DNAs and the
study of their charge transport properties. The conductance and current-voltage (I-V)
characteristics of a series of Te-doped DNA molecules are measured with scanning tunneling
microscope break junction technique (STM-BJ) in Au-DNA-Au junction systems. A comparison
between Te-modified, Se-modified and the native DNAs show that the tellurium modification can
effectively manipulate the electronic structure of DNA, and the location of the modification has a
significant impact on the resulting I-V characteristics of DNA. This work provides new insights
into charge transport through DNA molecules.
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5.2

Results and discussion
5.2.1

5-PhTe/PhSe-thymidine phosphoramidite and oligo synthesis

Figure 5.5 a. Au-DNA-Au molecular junction; b. chemical structure of Te and Se modified
thymidine; c. Native as well as modified DNA sequences
In this work, a 5-PhTe-modified thymidine derivative (TeT) were synthesized following the
method reported140 previously from our group with slight modification. Three corresponding TeDNA duplexes (5’-GTGTACAC-3’-SH), TeT-DNA 1, TeT-DNA 2 and TeT-DNA 3, containing TeT
bases at different locations were also synthesized (Figure 5.5 b and c). In the meanwhile, we also
synthesized corresponding selenium nucleobase-derivatized nucleoside (Figure 5.6) as well as SeDNA duplexes with same sequence for comparison. Note that one native DNA (N-DNA) of the
same sequence was also synthesized for control experiment. To make it attachable to the Au(111)
surface, all the DNAs containing a thiol tail at the 3’-end. By conducting the UV-thermal study,
we found that the

Te

T-DNA duplex has the thermo-stability similar to the corresponding native

duplex (Table 5.1). Circular dichroism was also used to study the structure change (Figure 5.11).
Positive peaks at 280 nm, 220 nm and negative peak at 245 nm were observed in all oligos, and
no shift was founded comparing to native DNA, which indicated that the native and Te-DNA has
similar helixes. Furthermore, our previous X-ray crystal structure studies of the Te-derivatized
DNAs indicate that the Te-derivatized and native structures are virtually identical, and that TeT and
A interact as well as the native T–A pair.140 These results suggest that the secondary structures,
including the hydrogen bond, π-π stacking between neighboring base pairs and helicity of the
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studied DNA duplexes are not perturbed by the tellurium modification. This allows isolating the
influence of Te-modification on the charge transport properties of DNA for in-depth investigation.

Scheme 5.6 The synthesis of 5-PhTe/Se-T phosphoramidite and DNAs
Table 5.1 UV melting study of self-complementary Te-DNA
Entry
DNA duplex
Tm (oC)
N-DNA

5’-GTGTACAC-3’

35.0 ± 0.2

T-DNA 1

5’-G( T)GTACAC-3’

34.5 ± 0.2

Te

T-DNA 2

5’-GTG( T)ACAC-3’

34.2 ± 0.3

Te

T-DNA 3

5’-G(TeT)G(TeT)ACAC-3’

33.1 ± 0.5

Te

5.2.2

Te

Te

STM-BJ conductance and Current-voltage (I-V) characteristics measurements

Collaborating with Kun Wang and Binqian Xu at University of Georgia, we further studied
the charge transportation properties of the DNAs containing

Se

T and

Te

T. By using scanning

tunneling microscope break junction technique (STM-BJ), we measured the single-molecule
conductance of these modified DNAs. An increase of single-molecule conductance was observed
for both selenium and tellurium modified DNA comparing to the native (Figure 5.6). We also
measured the single-molecule conductance for

Te

T-DNAs with the modification at different

location under two different bias (0.3V and 0.75V). Under 0.3V, all

Te

T-DNAs show greater

conductance than the native and follow the order of TeT-DNA 3 > TeT-DNA 2 > TeT-DNA 1 > N-
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DNA (native). However, surprisingly, when the applied bias increased to 0.75V, the conductance
difference follows the order of

Te

T-DNA 3 >

dramatic conductance increase of

Te

Te

T-DNA 1 >

Te

T-DNA 2 > N-DNA, caused by a

T-DNA 1, triple its conductance, comparing to other

Te

T-

DNAs which only have a slight increment.
We further performed the I-V characteristic measurements for both

Te

T-DNAs and

Se

T-

DNA, as well as the corresponding native DNA. The I-V curves averaged from around 50 singlemolecule I-V curves for each DNA molecule are shown in Fig. 5.7. Consistent with the static
conductance measurement results, all
importantly, the I-V curve of

Te

Te

T-DNAs yield higher current than the N-DNA. More

T-DNA 1 shows strong non-linear feature, which does not be

observed for other TeT-DNAs (Figure 5.7). A sharp increase in current occurs for Te-DNA 1 when
bias increases over 0.6V. A comparison between TeT-DNA 1 and SeT-DNA 1 reveals that the SeTDNA 1 alse shows the non-linear feature, however, which is much weaker than the

Te

T-DNA 1

indicating the tellurium modification has a stronger effect on the charge transport properties of
DNA than selenium.
5.3

Conclusion
We synthesized the 5-PhTe/Se-T phosphoramidite and DNAs containing these

modifications. These DNAs containing a thiol tail which makes it capable to attach on the Au
surface to form Au-DNA-Au junction system. Interestingly, with the tellurium modification on the
first thymidine from the 5’-end, the DNA shows special charge transport properties in the
conductance and I-V measurements. The position dependent, strong non-linear feature of the TeTDNA give insight into charge transport properties of modified DNAs. Since the non-linear currentvoltage characteristics are central to building functional electronic devices, this work could further
spur future design of functional DNA-based molecular devices.
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5.4

Experimental Section
5.4.1

General Section

Most solvents and reagents were purchased from Sigma, Fluka, or Aldrich and used
without purification unless mentioned otherwise. When necessary, solid reagents were dried under
high vacuum. Reactions with compounds sensitive to air or moisture were performed under argon.
Solvent mixtures are indicated as volume/volume ratios. Thin layer chromatography (TLC) was
run on Sorbtech Silica XHL TLC plates (0.25 mm thick; Rf values in the text are for the title
products), and visualized under UV-light or by a Ce-Mo staining solution (phosphomolybdate, 25
g; Ce(SO4)2·4H2O, 10 g; H2SO4, 60 mL, conc.; H2O, 940 mL) with heating. Flash chromatography
was performed using Sorbtech Silica gel (mesh size 0.040-0.063 mm) using a silica gel:crude
compound weight ratio of ca. 30:1. 1H-NMR and 13C-NMR spectra were recorded using a Bruker
Avance 400 or 600. All chemical shifts (d) are in ppm relative to tetramethylsilane and all coupling
constants (J) are in Hz. High resolution (HR) MS were either obtained with electrospray ionization
(ESI) on a Q-TOFTM Waters Micromass at Georgia State University.
5.4.2

The synthesis of 5-PhTe-thymidine phosphoramidite

3’-O-tert-Butyldimethylsilyl-5’-O-(4,4’-dimethoxytriphenylmethyl)-2’-deoxy-5iodouridine (5.1) was prepared with slight modification according to ref 1. 5‘-O-(4,4’dimethoxytrityl)-2’-deoxy-5-iodouridine (2 g, 3 mmol) and imidazole (0.61 g, 9 mmol) was placed
in RBF and dried over high vacuum 20 min. Anhydrous DMF (20 ml) was injected under argon
followed by the addition of tert-butyldimethylsilyl chloride (TBDMSCl) (0.69 g, 4.5 mmol). The
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mixture was stirred at room temperature for 2 h, and then quenched with MeOH. The mixture was
diluted with EtOAc (30 ml) and washed with H2O (3×10 ml) and brine. The organic phase was
dried over anhydrous MgSO4. After filtration, the solvent was concentrated under reduced pressure
and the residue was purified by a flash silica gel column (the silica gel was pre-equalized with 1%
Et3N in CH2Cl2, eluent: 20% EtOAc in hexanes) to give 5.1 (2.26 g, 98%). TLC condition:
EA:hexanes = 1:2; rf = 0.5. 1H-NMR (400 MHz, CDCl3):  8.96 (1H, br, NH, exchangeable with
D2O), 8.23 (1H, s, H-6), 7.46–7.26 (9H, m, Ar), 6.89–6.87 (4H, m, Ar), 6.31 (1H, dd, H-1’, J= 6,
7.2 Hz), 4.48 (1H, m, H-3’), 4.02 (1H, m, H-4’), 3.82 (6H, 2 s, CH3O), 3.44 (1H, dd, H-5’a, J=
2.8, 10.8 Hz), 3.30 (1H, dd, H-5’b, J= 2.8, 10.8 Hz), 2.41 (1H, ddd, H-2’a, J= 2.8, 5.6, 13.2 Hz),
2.22 (1H, m, H-2’b), 0.86 (9 H, 3 s, SiMe3), 0.05–0 (6H, 2s, SiMe2); 13C-NMR (100 MHz, CDCl3)
 160.01 (C4), 158.67 (Ar), 149.84 (C2), 144.38 (C-6), 144.30 (Ar), 135.48 (Ar), 135.37 (Ar),
130.11 (Ar), 130.05 (Ar), 128.12 (Ar), 128.05 (Ar), 127.09 (Ar), 113.39 (Ar), 113.36 (Ar), 87.38
(C4’), 86.99 (Ar), 85.79 (C-1’), 72.48 (C-3’), 68.42 (C-5), 63.01 (H5’), 55.30 (OMe), 42.05 (C2’),
25.74 (CCH3), 17.97 (CCH3), -4.67 (SiCH3), -4.86 (SiCH3);

13

C-HSQC, see Figure 1; UV (in

MeOH), λmax: 208 nm, 282 nm; HRMS (ESI-TOF): molecular formula: C36H42N2O7Si; [M-H]+:
769.1811 (calcd 769.1806). 1H-13C HSQC (Appendix D.4)

3’-O-tert-Butyldimethylsilyl-5’-O-(4,4-dimethoxytrityl)-2’-deoxy-5phenyltellurouridine (5.2) was prepared with slight modification according to literature140. Twoneck bottle flask was used. The Ph2Te2 was packaged by a tissue bag and placed in the flask. The
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bag was suspended above the solution during reaction. Under Argon, NaH 95 % (49 mg, 1.95
mmol) was placed in a two-neck round bottle flask. 5.1 (1 g, 1.3 mmol) was dissolve in dry THF
(20 mL) and injected to the flask at room temperature. The Ph2Te2 was wrapped by a piece of
tissue and suspended above the solution. The mixture was stirred for 30 min until no bubbling,
then cool down to -78 oC (place in an Acetone-dye ice bath) and treated with n-BuLi (2.3 mL, 2.5
M solution in hexane; 5.9 mmol) dropwise over 10 min. The mixture was further stirred for 30
min, and then a needle was used to break the tissue and release all the Ph2Te2 in the bag. The
mixture was further stirred for 2 h at -78 oC. Saturated NaCl solution (2 ml) was added to quench
the reaction. The reaction flask was warmed up to room temperature. Water (10 ml) was added to
the flask and EtOAc (3×20 ml) was used to extract the crude product. The organic phase was
combined and dried over MgSO4 (s). After filtration and evaporation, the residue was purified by
flash silica gel chromatography (eluent: 40% EtOAc in hexanes containing 1% Et3N) to give 5.2
(0.72 g, 65%) as a colorless foam. TLC condition: EA:hexanes = 1:2; rf = 0.4. 1H-NMR (400 MHz,
CDCl3), : 8.54 (1H, br, NH, exchangeable with D2O), 7.93 (1H, s, H-6), 7.67 (2H, d, Ar, J=6.8
Hz), 7.47 (2H, d, Ar, J=7.2 Hz), 7.39-7.23 (8H, m, Ar), 7.14 (2H, t, J=7.6 Hz), 6.88-6.85 (4H, m,
Ar), 6.29 (1H, m, H-1’), 4.30 (1H, m, H-3’), 4.00 (1H, m, H-4’), 3.82 (6H, 2 s, CH3O), 3.25 (2H,
m, H-5’a,b), 2.37 (1H, ddd, H-2’a, J= 3.2, 9.2, 13.2 Hz), 2.09 (1H, m, H-2’b), 0.87 (9H, 3 s,
SiMe3), 0.04–0 (6H, 2s, SiMe2); 13C-NMR (100 MHz, CDCl3)  162.75 (C4), 158.73 (Ar), 150.37
(C2), 147.15 (C6), 144.57 (Ar), 138.48 (Ar), 135.81 (Ar),135.61 (Ar), 130.24 (Ar), 130.20 (Ar),
128.57 (Ar), 128.36 (Ar), 128.23 (Ar), 128.11 (Ar), 127.13 (Ar), 113.37 (Ar), 113.22 (C5), 89.23
(Ar), 86.85 (C4’), 85.43 (C1’), 72.44 (C3’), 63.31 (C5’), 55.38 (OMe), 41.58 (C2’), 25.82 (CCH3),
18.04 (CCH3), -4.57 (SiCH3), -4.77 (SiCH3); 13C-HSQC, see Figure 2; UV (in MeOH), λmax: 204
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nm, 266 nm; HRMS (ESI-TOF): molecular formula: C42H48N2O7TeSi; [M+H+]+: 851.2367 (calcd
851.2371). 1H-13C HSQC (Appendix D.4)

5’-O-(4,4-dimethoxytrityl-2’-deoxy-5-phenyltellurouridine (5.3) TBAF (1 ml, 1M
solution in THF) was added to a solution of 5.2 (0.5 g, 0.7 mmol) in THF (10 ml) at 0 oC. The
mixture was stirred for 3 h at room temperature. The solvent was evaporated under reduced
pressure, and the residue was partitioned between EtOAc and H2O. The organic phase was dried
over anhydrous MgSO4 (s) before evaporation. The residue was then purified by silica gel column
chromatography (the silica gel was pre-equalized with 1% TEA in CH2Cl2; eluent: 4% MeOH in
CH2Cl2 containing 1% TEA) to give (0.4 g, 83%) of 5.3 as pale-yellow foam. 1H-NMR (CDCl3,
d): 9.18 (1H, br, NH, exchangeable with D2O), 7.83 (1H, s, H-6), 7.63–7.00 (15 H, m, Ar), 6.86–
6.81 (4H, m, Ar), 6.26 (1H, dd, H-1’, J=6.4, 6.8 Hz), 4.32 (1H, m, H-3’), 3.96 (1H, m, H-4’), 3.76
(6H, 2 s, CH3O), 3.27 (1H, dd, H-5’a, J=4.4, 10.4 Hz), 3.18 (1H, dd, H-5’b, J=4.4, 10.8 Hz), 2.39
(1H, m, H-2’a), 2.15 (1H, m, H-2’b); 1H-NMR spectrum is identical to the literature140.

3’-O-(2-cyanoethyl-N,N-diisopropylamino)-5’-O-(4,4-dimethoxytrityl)-2’-deoxy-5phenyltellurouridine (5.4). 5.3 (0.5 g, 0.68 mmol) was dried over high vacuum for 2 h and then
dissolved in CH2Cl2 (5 mL) under argon. Dimethylethylamine (0.44 mL, 4.1 mmol) was injected,
followed by the addition of N,N-diisopropylamino cyanoethylphosphamidic chloride (193 mg,
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0.82 mmol). The mixture was stirred for 1 h at room temperature. The solvent was evaporated
under reduced pressure and re-dissolved in minimal CH2Cl2. Slowly drop the solution into pentane
(500 mL) under vigorous stirring. The white precipitate was filtered out and purified by a short
silica gel column (eluent: 2 % MeOH and 1 % DMEA in DCM). The crude product was dissolved
in minimal CH2Cl2 and re-precipitated in pentane. The precipitate was filtered out again and dried
under high vacuum to give 5.4 (350 mg, 55%) as a mixture of two diastereomers.

31

P-NMR

(CDCl3, d): 149.3, 149.8; HRMS (ESI-TOF): molecular formula: C45H51N4O8PTe; [M-H+]:
935.252 (calcd 935.242)
5.4.3

The synthesis of 5-PhSe-thymidine phosphoramidite

3’-O-tert-Butyldimethylsilyl-5’-O-(4,4-dimethoxytrityl)-2’-deoxy-5phenylselenouridine (5.5). Two-neck bottle flask was used. The Ph2Se2 was packaged by a tissue
bag and placed in the flask. The bag was suspended above the solution during reaction. Under
Argon, NaH 95 % (49 mg, 1.95 mmol) was placed in a two-neck round bottle flask. 5.1 (1 g, 1.3
mmol) was dissolve in dry THF (20 mL) and injected to the flask at room temperature. The Ph2Se2
(1.4 g, 4.5 mmol) was wrapped by a piece of tissue and suspended above the solution. The mixture
was stirred for 30 min until no bubbling, then cool down to -78 oC (place in an Acetone-dye ice
bath) and treated with n-BuLi (2 mL, 2.5 M solution in hexane; 5.2 mmol) dropwise over 10 min.
The mixture was further stirred for 30 min, and then a needle was used to break the tissue and
release all the Ph2Se2 in the bag. The mixture was further stirred for 2 h at -78 oC. Saturated NaCl
solution (2 ml) was added to quench the reaction. The reaction flask was warmed up to room
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temperature. Water (10 ml) was added to the flask and EtOAc (3×20 ml) was used to extract the
crude product. The organic phase was combined and dried over MgSO4 (s). After filtration and
evaporation, the crude product was moved to next step without further purification.

5’-O-(4,4-dimethoxytrityl-2’-deoxy-5-phenyltellurouridine (5.6) TBAF (1 ml, 1M
solution in THF) was added to a solution of 5.5 (0.6 g, 0.7 mmol) in THF (10 ml) at 0 oC. The
mixture was stirred for 3 h at room temperature. The solvent was evaporated under reduced
pressure, and the residue was partitioned between EtOAc and H2O. The organic phase was dried
over anhydrous MgSO4 (s) before evaporation. The residue was then purified by silica gel column
chromatography (the silica gel was pre-equalized with 1% TEA in CH2Cl2; eluent: 4% MeOH in
CH2Cl2 containing 1% TEA) to give (0.4 g, 83%) of 5.6 as pale-yellow foam. 1H-NMR (400 MHz,
CDCl3) δ (ppm): 8.07 (1H, s, H-6), 7.43–7.20 (14 H, m, Ar), 6.86 (1H, d, H-1’, J=8.7 Hz), 6.81
(4H, dd, Ar, J=2.5, 8.9 Hz), 4.14 (1H, q, H-3’, J=7.2), 4.05 (1H, m, H-4’), 3.78 (6H, s, CH3O),
3.41 (1H, dd, H-5’a, J=3.2, 10.7 Hz), 3.33 (1H, dd, H-5’b, J=3.7, 10.1 Hz), 2.49 (1H, m, H-2’a),
2.29 (1H, m, H-2’b);

3’-O-(2-cyanoethyl-N,N-diisopropylamino)-5’-O-(4,4-dimethoxytrityl)-2’-deoxy-5phenyltellurouridine (5.7). 5.6 (0.5 g, 0.68 mmol) was dried over high vacuum for 2 h and then
dissolved in CH2Cl2 (5 mL) under argon. Dimethylethylamine (0.44 mL, 4.1 mmol) was injected,
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followed by the addition of N,N-diisopropylamino cyanoethylphosphamidic chloride (193 mg,
0.82 mmol). The mixture was stirred for 1 h at room temperature. The solvent was evaporated
under reduced pressure and re-dissolved in minimal CH2Cl2. Slowly drop the solution into pentane
(500 mL) under vigorous stirring. The white precipitate was filtered out and purified by a short
silica gel column (eluent: 2 % MeOH and 1 % DMEA in DCM). The crude product was dissolved
in minimal CH2Cl2 and re-precipitated in hexane. The precipitate was filtered out again and dried
under high vacuum to give 5.7 (350 mg, 55%) as a mixture of two diastereomers. HRMS (ESITOF): molecular formula: C45H51N4O8PSe; [M+H+]: 887.2635 (calcd 887.2690)
5.4.4

5-PhTe/PhSe-Uridine containing DNA synthesis and purification

All the DNA oligonucleotides were chemically synthesized in a 1.0 mmol scale using an
ABI3400 DNA/RNA Synthesizer. The ultra-mild nucleoside phosphoramidite reagents were used
in this work (Glen Research). The concentration of the Te-deoxy-uridine phosphoramidite was
identical to that of the conventional ones (0.1 M in acetonitrile). Coupling was carried out using a
5-ethyl thio-1H-tetrazole (ETT) solution (0.25 M) in acetonitrile. The coupling time was 25 s for
both native and 300 s for modified samples. Trichloroacetic acid (3%) in methylene chloride was
used for the 5’-detritylation. Synthesis were performed on control pore glass (3’-thiol-modifier C3
S-S CPG, see Figure 5.8) immobilized with the appropriate nucleoside through a succinate linker.
The modified CPG containing a disulfide bond which can be cleaved at room temperature in 30
min with 100 mM DTT pH 8.3 – 8.5 in the buffer after purification. All the oligonucleotides were
prepared with DMTr-on form. After synthesis, the DNA oligonucleotides were cleaved from the
solid support and fully deprotected by the treatment of 0.05 M K2CO3 solution in methanol for 8
h at room temperature. The 5’-DMTr deprotection was performed in a 10% acetic acid solution
for 1 h at 40 oC, followed by neutralization to pH 7.0 with a freshly made aqueous solution of
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triethylamine (1.1 M) and desalt with a waters certified Sep-Pak® cartridges to remove DMTr-OH.
The typical MS results of the 5-Te-T-containing DNAs are presented in Figure 5.9 and Table 5.3.

Figure 5.6 Structure of 3’-Thiol-Modifier C3 S-S CPG
4700 Reflector Spec #1 MC[BP = 2663.8, 9645]
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Figure 5.7 MALDI-TOF MS spectrum of 5'-G(TeT)GTACAC-3’.
Molecular formula: C89H114N30O50P8S2Te; [M]-: 2844.7 (calc. 2844.3)
Table 5.2 MS values of the 5-Te-T-containing DNAs
Entry
DNA sequencesa
1
GTGTACAC
C84H112N30O50P8S2
2
G(TeT)GTACAC
C89H114N30O50P8S2Te
3
GTG(TeT)ACAC
C89H114N30O50P8S2Te
4
G(TeT)G(TeT)ACAC
C94H116N30O50P8S2Te2
a.

3’-end of all DNA sequences:
5.4.5

Measured (calc.) m/z
[M+H]+: 2653.8 (2653.4)
[M]-: 2844.7 (2844.3)
[M+H]+: 2845.6 (2845.3)
[M+H]+: 3037.5 (3037.2)
;

UV-melting temperature and Circular dichroism experiements

The experiments were performed using the samples (2 μM DNA duplexes) dissolved in the
buffer of 150 mM NaCl, 10 mM NaH2PO4-Na2HPO4 (pH 6.5), 0.1 mM EDTA and 10 mM MgCl2.
The samples were heated up to 60 ºC and allowed to cool down to room temperature slowly. These
experiments were carried out by Cary 300 UV-Visible Spectrophotometer with a temperature
controller at a heating rate of 0.5 ºC/min.
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Figure 5.8 Normalized UV-melting curves of the native and corresponding Te-modified DNA.
The CD spectra were measured by using a Jasco J-810 Spectropolarimeter (JASCO, Japan)
with a 0.1-cm path-length quartz cell at 25 oC. The experiments were performed using samples (15
μM DNA duplexes) dissolved in the buffer of 25 mM Tris-HCl at pH 7.3 with 50 mM NaCl at 25
o

C. The CD spectrum was obtained by taking the average of three scans made at 0.1-nm intervals

from 200 to 350 nm.

Figure 5.9 CD spectra of the native and Te modified DNA
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APPENDICES
Appendix A. Computational study of the MeSe incorporation at 2’-position of uridine,
cytidine, thymidine and 5-F-uridine.
Appendix A.1 Calculation of the energy barrier for the MeSe incorporation

Figure A.1 Energy barrier calculation for MeSe incorporation.
The calculation of the energy barrier of MeSe incorporation for cytidine, thymidine, uridine
and 5-F-uridine derivatives were conducted and compared. We found that the Δ≠G of the reaction
is directly related to electron richness of the nucleobase following the order of cytosine > uracil >
thymine > 5-F-uracil. The 5-F-U give the lowest activation energy and the cytidine give the highest
one (Table A.1). Comparing with uridine, the activation energy is thymidine and cytidine give 0.3
and 3.2 kcal/mol higher respectively, which is consistent with our experiment that the temperature
of MeSe incorporation to thymidine require 95 oC instead of 50 oC for uridine. The higher energy
barrier may cause by the electron repelling between the electron-rich nucleobase with the selenium
atom.
Table A.1 Energy barriers of MeSe incorporation
Starting material

Energy of
S.M. (a.u.)

Energy of
T.S. (a.u.)

Δ‡G
(kcal/mol)

ΔΔ‡G
(kcal/mol)

2’-Ms-U + MeSe⊝

-1911.6947

-1911.6684

16.5437

-
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2’-Ms-T + MeSe⊝

-1950.9676

-1950.9407

16.9026

0.3589

2’-Ms-C + MeSe⊝

-1891.8093

-1891.7778

19.7534

3.2097

2’-Ms-F5U + MeSe⊝ -2010.9082

-2010.8836

15.4505

-1.0932

Appendix A.2 Computational structures and coordinates
Methods: Calculations were executed at Georgia State University using the Gaussian 09151
program with the M062X152 method. The 6-311G+(d)153 basis set for C, H, O, N and aug-cc-pVTZPP154 basis set for Se and S were used. The calculations did converge to transition state as
determined by the existence of one negative frequency, and further confirmed by Intrinsic reaction
coordinate (IRC) calculation. Molecular structures are rendered in GaussView5.0.9.155

Figure A.2 Transition state complex of the 2’-mesylate-uridine MeSe incorporation.
Table A.2 Coordinates of the transition state of MeSe incorporation of 2’-Ms-uridine
Coordinates (Angstroms)
Atomic
Number
X
Y
Z
8
-0.587796
4.433391
-1.661506
6
-0.857744
3.739902
-0.4226
1
-1.721221
4.217783
0.031803
1
-0.002313
3.810077
0.255743
6
-1.152338
2.286944
-0.68327
1
-2.013054
2.156962
-1.337593
8
0.04759
1.748414
-1.351783
6
0.115453
0.327177
-1.132987
1
-0.31649
-0.210879
-1.970246
7
1.51935
-0.064471
-1.052132
6
2.523508
0.841459
-0.778096
6
3.807315
0.456821
-0.627512
1
4.587564
1.163413
-0.408685

117

6
8
7
6
8
6
6
8
1
1
1
1
34
6
1
1
1
16
6
1
1
1
8
8
1
8
1

4.163879
5.306243
3.071828
1.749836
0.830235
-1.327566
-0.756761
-2.68764
-0.691585
-3.056882
2.189224
0.049028
1.295527
-0.209188
0.109502
-1.054495
-0.538516
-3.124667
-2.190368
-2.779738
-2.026788
-1.229373
-4.31142
-3.32768
-0.720875
-2.198561
3.260587

-0.94039
-1.41748
-1.788827
-1.426803
-2.256627
1.425857
0.08356
1.465076
1.807116
0.570172
1.861099
3.902407
0.162592
-0.18956
-0.006679
0.466515
-1.22458
-1.514671
-3.013507
-3.813045
-3.184468
-2.903748
-1.625901
-1.287367
-0.807799
-0.421136
-2.780379

-0.718587
-0.617096
-0.957079
-1.076536
-1.214742
0.570164
0.108624
1.009338
1.365092
1.157471
-0.697564
-2.170031
2.011721
3.232151
4.256638
3.009598
3.142654
-0.402403
-0.57325
-0.130218
-1.634079
-0.075909
-1.229347
1.035738
0.704214
-0.948731
-0.958042

Figure A.3 Transition state complex of the 2’-mesylate-cytidine MeSe incorporation
Table A.3 Coordinates of the transition state of MeSe incorporation of 2’-Ms-cytidine
Coordinates (Angstroms)
Atomic
Number
X
Y
Z
8
-0.685755
4.367188
-1.850324
6
-0.952199
3.702451
-0.595537
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1
1
6
1
8
6
1
7
6
6
1
6
7
6
8
6
6
8
1
1
1
1
34
6
1
1
1
16
6
1
1
1
8
8
1
8
7
1
1

-1.848927
-0.121148
-1.171203
-1.990004
0.079607
0.153438
-0.264323
1.551221
2.553516
3.835196
4.637587
4.073074
3.084122
1.793604
0.807666
-1.381862
-0.73611
-2.767136
-0.810559
-3.064536
2.249779
0.062039
1.223127
-0.297253
-0.010621
-0.611695
-1.141247
-3.072972
-2.188763
-2.14523
-1.179136
-2.7335
-4.310246
-3.230045
-0.695919
-2.161355
5.324639
6.115468
5.462808

4.155174
3.839993
2.22845
2.041394
1.707006
0.289337
-0.269486
-0.099673
0.813387
0.401105
1.107471
-1.011255
-1.902024
-1.484815
-2.262948
1.411364
0.072228
1.407263
1.855201
0.516637
1.846089
3.924973
0.317782
0.28643
-0.231178
1.298437
-0.244043
-1.620789
-3.143692
-3.388921
-3.006146
-3.903999
-1.7133
-1.344588
-0.802732
-0.55712
-1.491769
-0.887149
-2.487357

-0.181333
0.101045
-0.812058
-1.506436
-1.386872
-1.138106
-1.969071
-1.013402
-0.853338
-0.690892
-0.563495
-0.685948
-0.825578
-0.961054
-1.035118
0.466594
0.094149
0.832409
1.275747
1.11167
-0.866632
-2.287295
2.023866
3.279093
4.191688
3.53002
2.830344
-0.359478
-0.522508
-1.580924
-0.139652
0.031952
-1.122723
1.081438
0.712859
-0.970704
-0.543056
-0.414545
-0.528701
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Figure A.4 Transition state complex of the 2’-mesylate-thymidine MeSe incorporation
Table A.4 Coordinates of the transition state of MeSe incorporation of 2’-Ms-thymidine
Coordinates (Angstroms)
Atomic
Number
X
Y
Z
8
-0.449133
4.506427
-1.494338
6
-0.746372
3.770599
-0.287432
1
-1.574589
4.279513
0.198084
1
0.11627
3.759592
0.383908
6
-1.134725
2.352321
-0.612308
1
-1.987234
2.313798
-1.289138
8
0.035186
1.747472
-1.273356
6
-0.015252
0.318651
-1.11962
1
-0.481145
-0.145935
-1.98247
7
1.349189
-0.193631
-1.034807
6
2.434225
0.627246
-0.780005
6
3.682948
0.14366
-0.606122
6
3.888615
-1.291708
-0.681735
8
4.989589
-1.862318
-0.550107
7
2.738381
-2.044446
-0.924577
6
1.457833
-1.565483
-1.062521
8
0.462966
-2.310368
-1.197929
6
-1.395853
1.459434
0.604774
6
-0.916069
0.09558
0.105802
8
-2.759324
1.569743
1.028944
1
-0.750876
1.769538
1.422895
1
-3.167057
0.692354
1.183101
1
2.197706
1.676957
-0.730039
1
0.237088
4.031223
-1.993304
34
1.082413
-0.068075
2.031725
6
-0.450975
-0.338717
3.239244
1
-0.126146
-0.240735
4.272826
1
-1.223348
0.409246
3.046627
1
-0.876617
-1.330738
3.093484
16
-3.422864
-1.281628
-0.478165
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6
1
1
1
8
8
1
8
1
6
1
1
1

-2.69013
-3.324964
-2.63645
-1.686917
-4.654446
-3.55897
-0.979754
-2.403193
2.843662
4.872673
5.648818
4.592573
5.306868

-2.863263
-3.616602
-3.003952
-2.873598
-1.181293
-1.121681
-0.825741
-0.262733
-3.049961
1.006672
0.861529
2.05795
0.750756

-0.780877
-0.320737
-1.857637
-0.359521
-1.247437
0.980816
0.651299
-0.991594
-0.943686
-0.319169
-1.071191
-0.305
0.647999

Figure A.5 Transition state complex of the 2’-mesylate-5-fluoro-uridine MeSe incorporation
Table A.5 Coordinates of the transition state of MeSe incorporation of 2’-Ms-5-F-uridine
Coordinates (Angstroms)
Atomic
Number
X
Y
Z
8
-0.484896
4.529249
-1.434548
6
-0.756562
3.768745
-0.237418
1
-1.578887
4.263883
0.27184
1
0.117222
3.749436
0.419191
6
-1.145546
2.355034
-0.580651
1
-2.004138
2.325317
-1.24991
8
0.018584
1.760974
-1.264096
6
-0.022772
0.332507
-1.125083
1
-0.485523
-0.130576
-1.99016
7
1.349982
-0.163624
-1.051241
6
2.412778
0.675441
-0.791473
6
3.639837
0.169892
-0.613281
6
3.916494
-1.245631
-0.664043
8
5.0255
-1.777631
-0.507174
7
2.772272
-2.000887
-0.923721
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6
8
6
6
8
1
1
1
1
34
6
1
1
1
16
6
1
1
1
8
8
1
8
1
9

1.482353
0.50239
-1.394889
-0.908431
-2.758141
-0.750421
-3.157337
2.190246
0.206961
1.112496
-0.404918
-0.071235
-1.189761
-0.816835
-3.410027
-2.671711
-3.305208
-2.61509
-1.670382
-4.647288
-3.534399
-0.96213
-2.398427
2.887572
4.713149

-1.53774
-2.294549
1.443694
0.088706
1.54037
1.747473
0.659215
1.727732
4.078446
-0.076308
-0.391185
-0.305817
0.348675
-1.386837
-1.299079
-2.87369
-3.635901
-2.998186
-2.888331
-1.196372
-1.155481
-0.83926
-0.270068
-3.005711
1.001687

-1.073062
-1.21405
0.625452
0.107317
1.052781
1.446306
1.207975
-0.743251
-1.947903
2.003566
3.218391
4.250098
3.045883
3.059189
-0.474258
-0.799676
-0.35249
-1.878248
-0.374175
-1.233322
0.987251
0.642574
-0.985099
-0.940303
-0.354198
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Appendix B. The mechanism study of the ring-opening of uracil through the
nucleophilic attack of methylselenium
During the synthesis of 2’-β-MeSe-uridine, a new reaction was observed when we use the
tert-butyloxycarbonyl (BOC) as the protective for the N3 (Scheme B.1). With the BOC protection,
the MeSe nucleophile attack the C-4 directly instead of the leaving group on the 2’-position.
Further computational study indicates that it is the intramolecular interaction between lone pair on
the 4-O and the π* of the carbonyl group of the BOC activating the nucleobase for the MeSe
nucleophilic attack. The cleavage of the mesylate group is also require which probably compensate
the energy rising due to the break of the aromatic ring. The effect of counterion was also examined
and reveals that stronger Lewis acid would facilitate the cleavage of BOC group instead of ringopening of the nucleobase.
Appendix B.1. Synthesis of selenolester and characterization

Scheme B.1 Conversion of uridine to its selenoester
The 3’,5’-OH groups of the uridine were protected with tetraisopropyldisilylene (TIPDS),
followed by the in-situ protection of 2’-OH group with trimethylsilyl (TMS) give B.1. With the
hydroxyl group fully protected, the BOC group can be introduced to N3 give B.2, followed by the
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deprotection of 2’-OTMS by treating with p-toluenesulfonic acid (TsOH). Then the 2’-OH group
of B.3 was activated with mesylate. The MeSeLi nucleophile was generated by treating the
dimethyldiselenide with n-BuLi under -78oC followed by the injection of B.4. The reaction only
took 15 min to complete under room temperature generating a new compound B.5 with 50% yield
and a byproduct B.6. B.5 was further deprotected with 3HF∙TEA to remove the TIPDS generating
B.7 as final product.

Figure B.1 The 1HNMR and 13CNMR of B.7
To confirm the structure of the new compound B.7, lots of spectroscopy studies were
conducted including NMR (Fig. B.1, B.2), IR (Fig. B.3), MS (Fig. B.4) and UV (Fig. B.5). MeSe
functionality were observed in both 1HNMR, 13CNMR, and further confirmed with MS. Because
of electron shield of selenium, MeSe group shift to high field in

13

CNMR at 4.8 ppm. The

connection between the proton and carbon of MeSe group was confirmed with 2D HSQC (Fig.
B.2). Based on the 1HNMR, both the BOC group and 2’-mesylate were cleaved. Both H-6 and H5 were observed with an increased the J-coupling of 14 Hz instead of 8 Hz for uridine, which
indicates the break of the aromatic system. The doublet of the 1’-H exhibiting in B.5 and B.7
suggests a conformation change of the sugar pucker caused by nucleophilic attack of the O-2 at
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the 2’-mesylate. Due to the direct connection with selenium, the 13C chemical shift of C-4 largely
shift from 160 ppm in B.4 to 190 ppm (Fig. B.1).
The 2D HMBC and HSQC reveals the connections between C-C and C-H (Fig. B.2). The
N-H shows cross peak between C-2, C-1’ and C-2’ instead of C-4 or C-5 confirming the break of
the nucleobase ring. The cross peaks between SeCH3 – 5-H and SeCH3 – C-4 were observed in
HMBC suggesting that the MeSe functionality is connected to C-4 rather than C-2’.

Figure B.2 1H-13C HMBC, HSQC and 1H-1H COSY of B.7
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In the infrared (IR) spectrum, three different double bond, C=O, C=C, C=N, were observed
at 1720 cm-1, 1669 cm-1 and 1594 cm-1 respectively (Fig. B.3, a). Moreover, a UV comparison
between B.7 and uridine was also conducted. A new peak at 300 nm was observed indicating the
change of the nucleobase which is consistent with our NMR results (Fig. B.3, b). The molecule
weight was measured by HRMS using electrospray ionization (ESI) as ion source. The molecular
ion peak was observed at 323.0125 with the typical selenium isotopes distribution (Fig. B.4).

Figure B.3 a. IR of B.7; b. UV spectra of B.7 and uridine.

Figure B.4 HRMS(ESI) of B.7
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Appendix B.2 The effect of BOC group for ring-opening
The reaction generated B.6 as the major byproduct which only lose the BOC group with
the mesylate retained. This imply that the BOC group is necessary for the reaction. To understand
the effect of BOC group activating the nucleobase, we conducted the same reaction with different
protective groups on N3 (Scheme B.2, b). However, without BOC group, no reaction happened at
room temperature overnight. When rise the temperature to 60 oC, the MeSe functionality substitute
the leaving group at 2’-position generating the 2’-β-MeSe-modified uridine derivatives. Without
any protective groups on the N3 (Scheme B.2, c), under room temperature and 50 oC, only 2’-βMeSe-incorporated products were observed. These results demonstrate that the BOC group is
required for the reaction.

Scheme B.2 Examine the effect of the BOC group
The role of BOC playing in the reaction is now clean. However, how BOC group activated
the nucleobase is still not understood. A computational study of the second order orbital
perturbation using the natural bond orbital (NBO) calculation in Gaussian09W shows that there is
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a significant interaction between the long pair of O-4 and the π* orbital of the BOC (Fig. B.5)
which is about 2.0 kcal/mol (Table B.1). Thus, the BOC group may serve as an intramolecular
Lewis acid, which lowering the energy of π* orbital of the carbonyl group at 4-position making it
more vulnerable to the attack of nucleophiles.

Figure B.5 Orbital interaction of n-π*
Table B.1 Calculated energy of the n-π* interaction
Second order perturbation
Method
(kcal/mol)
B3lyp/def-TZVP
1.64
B3lyp/6-31g+(d)
2.00
HF/6-31g+(d)
2.04
Appendix B.2 The effect of Leaving group and counterion
Even the activation of BOC group makes the reaction kinetically possible by lowering the
energy barrier. However, the reaction might be still thermodynamically unfavored since the break
of the aromatic system would cause significant energy penalty. Thus, we expect that the cleavage
of the leaving group is also necessary to compensate the energy rising. Several reactions with
different group at 2’-position were performed (Scheme B.3). Different leaving group give the same
product. However, with a poor leaving group TMS on the 2’-O, only the BOC cleaved by-product
was observed. These results are in accordance with our hypothesis that a good leaving group at 2’position is required.
As we proved previously, the BOC group acts as an intramolecular Lewis acid to activate
the nucleobase. In the reaction condition, there is Li+ ion which could also serves as Lewis acid
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coordinating with carbonyl group. To examine the effect of counterions of MeSe, we generated
MeSe nucleophiles under different conditions with different ion including Na+, Li+ and Mg2+
(Scheme B.4). When using Na+ as the counterion which is a poor Lewis acid, the MeSe
nucleophile still attack the 4-position give the ring-opening product (Scheme B.4, b). Interestingly,
unlike treated with MeSeLi, the BOC group still retain on the N3. When treated with (MeSe)2Mg,
the stronger Lewis acid Mg2+ directly cleave the BOC group without giving the desired product
(Scheme B.4, c). The results reveal that the counterion only activate the cleavage of BOC group
instead of activating the nucleobase.

Scheme B.3 Examine the effect of leaving group at 2’-position

Scheme B.4 Examine the effect of different counterion of the MeSe nucleophile.

129

Appendix B.3 Proposed mechanism
Here, we proposed a possible mechanism for the ring-opening reaction (Scheme B.5). With
the activation of BOC group, the MeSe- acts as nucleophile attack the C-4. Then, the 2-O serves
as another nucleophile substitute the 2’-OMs which compensate the energy increasing due to the
break of the aromatic ring. The Li+ ion acts as Lewis acid facilitate the in-situ deprotection of the
BOC group giving the selenolester as the final product.

Scheme B.5 Proposed mechanism.
Appendix B.4 Convert selenolester to its derivatives
Both selenolester B.5 and B.7 are relatively reactive to nucleophilic attack and several
functional groups can be easily introduced (Scheme B.6).

Scheme B.6 Convert selenolester to its derivatives
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Appendix B.5 Experimental section

Se-methyl-(Z)-3-((3aR,5R,6R,6aS)-5,6-O-(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)5-methylene-2-iminotetrahydrofuro[2,3-d]oxazol-3(2H)-yl)prop-2-eneselenoate

(B.5)

Dimethyldiselenide (1.7 mL, 18 mmol) was dissolved in 10 mL anhydrous THF in a flask and
cooled down to -78 oC in a acetone-dry ice bath. n-BuLi (4.8 mL, 2.5 M in hexane, 12 mmol) was
slowly injected into the solution and stirred for 10 min and then warm up to 0 oC. B.4 (2 g, 3.0
mmol) was dissolved in 20 mL anhydrous THF and injected into the reaction. The reaction was
warmed up to room temperature and stirred for 15 min then quenched with water (1 mL). The
mixture was diluted with EtOAc (30 ml) and washed with H2O (3×10 ml) and brine. The organic
phase was dried over anhydrous MgSO4. After filtration, the solvent was concentrated under
reduced pressure and the residue was purified by a flash silica gel column (eluent: 10 to 25 % ethyl
acetate in hexane) given B.5 as white solid (0.8 g, 45 %). 1H-NMR (400 MHz, CDCl3) δ (ppm):
1.04-1.10 (m, 28H, 4×iPrSi), 2.31 (s, 3H, SeCH3), 3.86 (dd, J1=3.2 Hz, J2= 6.7 Hz, 1H, H-4’), 3.90
(dd, J1=5.9 Hz, J2= 12.1 Hz, 1H, Ha-5’), 4.06 (dd, J1=3.2 Hz, J2= 12.1 Hz, 1H, Hb-5’), 4.21-4.24
(m, 1H, H-2’), 4.27 (dd, J1=4.2 Hz, J2= 6.9 Hz, 1H, H-3’), 5.69 (d, J=7.2 Hz, 1H, H-1’), 5.93 (d,
J=14.1 Hz, 1H, H-5), 7.86 (d, J=14.1 Hz, 1H, H-6). 13C-NMR (100 MHz, DMSO-d6) δ (ppm): 4.8
(SeCH3), 12.5, 12.7, 13.2, 13.4, 16.9, 17.2, 17.3, 17.4 (i-Pr), 61.9 (C-2’), 62.3 (C-5’), 80.0 (C-3’),
83.3 (C-4’), 85.6 (C-1’), 109.9 (C-5), 133.3 (C-6), 154.9 (C-2), 190.1 (C-4). HRMS (ESI):
C22H40N2O6SeSi2; [M+H]+: 564.1675 (calc. 564.1670).
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Se-methyl-(Z)-3-((3aR,5R,6R,6aS)-6-hydroxy-5-(hydroxymethyl)-2-iminotetrahydrofuro[2,3-d]oxazol-3(2H)-yl)prop-2-eneselenoate (B.7) Compound B.5 (0.56 g, 1.0
mmol) was dissolved in 10 mL anhydrous THF, and treated with 3HF·Et3N (0.16 mL, 1.0 mmol)
at 40 oC for 2 h. The mixture was evaporated to dryness, and the residue was purified by flash
column chromatography on silica gel (5% MeOH in methylene chloride) to afford pure product
B.7 ( 318 mg, 99%) as white solid. 1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.20 (s, 3H, SeCH3),
3.19-3.30 (m, 2H, H-5’), 3.93 (t, J=6.4 Hz, 1H, H-4’), 4.02-4.03 (m, 2H, H-2’, H-3’), 4.90 (t, J=5.3
Hz, 1H, OH-5’), 5.56 (d, J=4.2 Hz, 1H, OH-3’), 5.87 (d, J=14.0 Hz, 1H, H-5), 5.92 (d, J=6.5 Hz,
1H, H-1’), 7.61 (d, J=14.0 Hz, 1H, H-6), 8.42 (s, 1H, NH).

13

C-NMR (100 MHz, DMSO-d6) δ

(ppm): 4.8 (SeCH3), 61.9 (C-5’), 62.8 (C-2’), 76.2 (C-3’), 87.5 (C-1’), 89.2 (C-4’), 107.4 (C-5),
134.5 (C-6), 154.7 (C-2), 189.3 (C-4). HRMS (ESI): C10H14N2O5Se; [M+H]+: 323.0125 (calc.
323.0146). 1H-13C HSQC, 1H-13C HMBC and 1H-1H COSY (Figure B.2).

Methyl-(Z)-3-((3aR,5R,6R,6aS)-6-hydroxy-5-(hydroxymethyl)-2-iminotetrahydrofuro[2,3-d]oxazol-3(2H)-yl)-acrylate (B.8) Compound B.7 was treated with 5 mL
K2CO3 MeOH solution
(50 mM). The reaction stirred at room temperature for 3 hr. The mixture was evaporated
to dryness, and the residue was purified by flash column chromatography on silica gel (5% MeOH
in methylene chloride) to afford pure product B.8 ( 25 mg, 95%). 1H-NMR (400 MHz, DMSO-d6)
δ (ppm): 3.20-3.30 (m, 2H, H-5’), 3.64 (s, 3H, OCH3), 3.93 (t, J=6.5 Hz, 1H, H-4’), 4.03 (m, 2H,
H-2’, H-3’), 4.89 (t, J=4.9 Hz, 1H, OH-5’), 5.34 (d, J=14.5 Hz, 1H, H-5), 5.55 (d, J=3.7 Hz, 1H,
OH-3’), 5.91 (d, J=6.4 Hz, 1H, H-1’), 7.63 (d, J=14.1 Hz, 1H, H-6), 8.29 (s, 1H, NH).
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(Z)-5-((3aR,5R,6R,6aS)-5,6-O-(1,1,3,3‐tetraisopropyldisiloxane‐1,3‐diyl)-5methylene-2-imino-tetrahydrofuro[2,3-d]oxazol-3(2H)-yl)-3-oxopent-4-enenitrile (B.9) 0.01
mL acetonitrile was added to 2 mL THF and was cooled to -78oC in a acetone-dry ice bath,
followed with the injection of n-BuLi (0.2 mL, 2.5 M, 1.6 mmol). After stirring for 20 min, the
compound B.5 (300 mg, 0.5 mmol) was dissolved in 3 mL THF and injected under room
temperature. The reaction was stirred at room temperature for another 15 min and quenched with
water. The mixture was evaporated to dryness, and the residue was purified by flash column
chromatography on silica gel (40% ethyl acetate in hexane) to afford pure product B.9 (140 mg,
55%). 1H-NMR (400 MHz, CDCl3) δ (ppm): 1.01-1.06 (m, 28H, 4×iPrSi), 3.56 (s, 2H, CH2CN),
3.81-3.84 (m, 1H, H-4’), 3.88 (dd, J1=5.6 Hz, J2=12.2 Hz, 1H, Ha-5’), 4.02 (dd, J1=3.1 Hz, J2=12.2
Hz, 1H, Ha-5’), 4.21-4.26 (m, 2H, H-2’, H-3’), 5.70 (d, J=6.8 Hz, 1H, H-1’), 5.93 (d, J=14.2, 1H,
H-5), 6.88 (s, 1H, NH), 7.90 (d, J=14.2 Hz, 1H, H-6). 13C-NMR (100 MHz, CDCl3) δ (ppm): 12.5,
12.7, 13.1, 13.4, 16.9, 17.2, 17.3, 17.4 (i-Pr), 30.7 (CH2CN), 61.9 (C-2’, C-5’), 79.5 (C-3’), 83.4
(C-4’), 85.2 (C-1’), 104.3 (C-5), 114.4 (CN), 138.9 (C-6), 154.7 (C-2), 185.3 (C-4).

2-hydroxyethyl-(Z)-3-((3aR,5R,6R,6aS)-6-hydroxy-5-(hydroxymethyl)-2-iminotetrahydrofuro[2,3-d]oxazol-3(2H)-yl)-acrylate (B.10) The compound B.5 (300 mg, 0.5 mmol)
was dissolved in a mixture of THF and ethylene glycol (5 mL, v/v 1:1), followed with the addition
of triethylamine (0.14 mL, 1 mmol). The reaction was heated up to 60 oC overnight. The mixture
was evaporated to dryness, and the residue was purified by flash column chromatography on silica
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gel (4 % MeOH in methylene chloride) to afford pure product B.10 (252 mg, 95%). 1H-NMR (400
MHz, CDCl3) δ (ppm): 1.02-1.07 (m, 28H, 4×iPrSi), 2.56 (br, 1H, OH), 3.83-3.89 (m, 4H, Ha-5’,
H-4’, CH2CH2OH), 4.04 (dd, J1=2.6 Hz, J2=11.7 Hz, 1H, Hb-5’), 4.20-4.22 (m, 1H, H-2’), 4.244.27 (m, 3H, H-3’, CH2CH2OH), 5.51 (d, J=14.3 Hz, 1H, H-5), 5.68 (d, J=7.1 Hz, 1H, H-1’), 7.90
(d, J=14.3 Hz, 1H, H-6). 13C-NMR (100 MHz, CDCl3) δ (ppm): 12.5, 12.7, 13.2, 13.4, 16.9, 17.2,
17.3, 17.4 (i-Pr), 61.4 (CH2CH2OH), 62.1 (C-2’), 62.4 (C-5’), 65.9 (CH2CH2OH), 80.1 (C-3’),
83.3 (C-4’), 85.7 (C-1’), 98.8 (C-5), 137.5 (C-6), 155.1 (C-2), 167.5 (C-4).
Computational study
Calculations were executed at Georgia State University using the Gaussian09W151 program
with the B3LYP156-158 and HF159 method. The basis set 6-31G+(d)160, 161, def-TZVP162 were used.
The second order perturbation was calculated by natural bond orbital (NBO) version 3.1163 in
Gaussian09W. Molecular structures are rendered in GaussView5.0.9.155
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Appendix C. Nucleic Acid Mini Screen Reagent Formulation
Tube#
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.

Precipitant
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol
10% v/v (+/-)-2-Methyl-2,4pentanediol

Buffer
0.040 M Sodium cacodylate trihydrate pH
5.5
0.040 M Sodium cacodylate trihydrate pH
5.5
0.040 M Sodium cacodylate trihydrate pH
5.5
0.040 M Sodium cacodylate trihydrate pH
5.5
0.040 M Sodium cacodylate trihydrate pH
6.0
0.040 M Sodium cacodylate trihydrate pH
6.0
0.040 M Sodium cacodylate trihydrate pH
6.0
0.040 M Sodium cacodylate trihydrate pH
6.0
0.040 M Sodium cacodylate trihydrate pH
6.0
0.040 M Sodium cacodylate trihydrate pH
6.0
0.040 M Sodium cacodylate trihydrate pH
6.0
0.040 M Sodium cacodylate trihydrate pH
6.0
0.040 M Sodium cacodylate trihydrate pH
6.0
0.040 M Sodium cacodylate trihydrate pH
7.0
0.040 M Sodium cacodylate trihydrate pH
7.0
0.040 M Sodium cacodylate trihydrate pH
7.0
0.040 M Sodium cacodylate trihydrate pH
7.0
0.040 M Sodium cacodylate trihydrate pH
7.0
0.040 M Sodium cacodylate trihydrate pH
7.0
0.040 M Sodium cacodylate trihydrate pH
7.0
0.040 M Sodium cacodylate trihydrate pH
7.0
0.040 M Sodium cacodylate trihydrate pH
7.0
0.040 M Sodium cacodylate trihydrate pH
7.0
0.040 M Sodium cacodylate trihydrate pH
7.0

Polyamine
0.020 M Hexamine cobalt(III) chloride

Monovalent Ion
None

Divalent Ion
0.020 M Magnesium chloride hexahydrate

0.020 M Hexamine cobalt(III) chloride

0.080 M Sodium chloride

0.020 M Magnesium chloride hexahydrate

0.020 M Hexamine cobalt(III) chloride

None

0.020 M Hexamine cobalt(III) chloride

0.012 M Sodium chloride,
0.080 M Potassium chloride
0.040 M Lithium chloride

0.012 M Spermine tetrahydrochloride

0.080 M Potassium chloride

0.020 M Magnesium chloride hexahydrate

0.012 M Spermine tetrahydrochloride

0.080 M Potassium chloride

None

0.012 M Spermine tetrahydrochloride

0.080 M Sodium chloride

0.020 M Magnesium chloride hexahydrate

0.012 M Spermine tetrahydrochloride

0.080 M Sodium chloride

None

0.012 M Spermine tetrahydrochloride

0.020 M Magnesium chloride hexahydrate

0.012 M Spermine tetrahydrochloride

0.080 M Sodium chloride,
0.012 M Potassium chloride
0.012 M Sodium chloride,
0.080 M Potassium chloride
0.080 M Sodium chloride

0.012 M Spermine tetrahydrochloride

0.080 M Potassium chloride

0.020 M Barium chloride

0.012 M Spermine tetrahydrochloride

None

0.080 M Strontium chloride hexahydrate

0.012 M Spermine tetrahydrochloride

0.080 M Potassium chloride

0.020 M Magnesium chloride hexahydrate

0.012 M Spermine tetrahydrochloride

0.080 M Potassium chloride

None

0.012 M Spermine tetrahydrochloride

0.080 M Sodium chloride

0.020 M Magnesium chloride hexahydrate

0.012 M Spermine tetrahydrochloride

0.080 M Sodium chloride

None

0.012 M Spermine tetrahydrochloride

0.020 M Magnesium chloride hexahydrate

0.012 M Spermine tetrahydrochloride

0.080 M Sodium chloride,
0.012 M Potassium chloride
0.012 M Sodium chloride,
0.080 M Potassium chloride
0.080 M Sodium chloride

0.012 M Spermine tetrahydrochloride

0.080 M Potassium chloride

0.020 M Barium chloride

0.012 M Spermine tetrahydrochloride

0.040 M Lithium chloride

0.080 M Strontium chloride hexahydrate,

0.012 M Spermine tetrahydrochloride

0.040 M Lithium chloride

0.020 M Magnesium chloride hexahydrate

0.012 M Spermine tetrahydrochloride

None

0.080 M Strontium chloride hexahydrate

0.012 M Spermine tetrahydrochloride

0.012 M Spermine tetrahydrochloride

0.020 M Magnesium chloride hexahydrate

None
0.020 M Barium chloride

None
0.020 M Barium chloride
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Appendix D. Characterization of key compounds
Appendix D.1 NMR and MS Spectra for 2’-MeSe-arabinothymidine modification
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Appendix D.2 NMR and MS Spectra for 2’-MeSe-arabinocytidine modification
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Appendix D.3 NMR and MS spectra for 2’-MeSe-arabinouridine modification
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